0000914025April 32021Q2falseP6MP11MP3M00009140252020-03-292020-09-26xbrli:shares00009140252020-10-26iso4217:USD00009140252020-09-2600009140252020-03-280000914025us-gaap:ProductMember2020-06-282020-09-260000914025us-gaap:ProductMember2019-06-302019-09-280000914025us-gaap:ProductMember2020-03-292020-09-260000914025us-gaap:ProductMember2019-03-312019-09-280000914025us-gaap:ServiceMember2020-06-282020-09-260000914025us-gaap:ServiceMember2019-06-302019-09-280000914025us-gaap:ServiceMember2020-03-292020-09-260000914025us-gaap:ServiceMember2019-03-312019-09-2800009140252020-06-282020-09-2600009140252019-06-302019-09-2800009140252019-03-312019-09-28iso4217:USDxbrli:shares00009140252019-03-3000009140252019-09-280000914025us-gaap:CommonStockMember2020-06-270000914025us-gaap:AdditionalPaidInCapitalMember2020-06-270000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-270000914025us-gaap:RetainedEarningsMember2020-06-270000914025us-gaap:TreasuryStockMember2020-06-2700009140252020-06-270000914025us-gaap:RetainedEarningsMember2020-06-282020-09-260000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-282020-09-260000914025us-gaap:CommonStockMember2020-06-282020-09-260000914025us-gaap:AdditionalPaidInCapitalMember2020-03-292020-09-260000914025us-gaap:AdditionalPaidInCapitalMember2020-06-282020-09-260000914025us-gaap:TreasuryStockMember2020-06-282020-09-260000914025us-gaap:CommonStockMember2020-03-292020-09-260000914025us-gaap:CommonStockMember2020-09-260000914025us-gaap:AdditionalPaidInCapitalMember2020-09-260000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-260000914025us-gaap:RetainedEarningsMember2020-09-260000914025us-gaap:TreasuryStockMember2020-09-260000914025us-gaap:CommonStockMember2019-06-290000914025us-gaap:AdditionalPaidInCapitalMember2019-06-290000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-290000914025us-gaap:RetainedEarningsMember2019-06-290000914025us-gaap:TreasuryStockMember2019-06-2900009140252019-06-290000914025us-gaap:RetainedEarningsMember2019-06-302019-09-280000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-302019-09-280000914025us-gaap:CommonStockMember2019-06-302019-09-280000914025us-gaap:AdditionalPaidInCapitalMember2019-06-302019-09-280000914025us-gaap:TreasuryStockMember2019-06-302019-09-280000914025us-gaap:CommonStockMember2019-09-280000914025us-gaap:AdditionalPaidInCapitalMember2019-09-280000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-280000914025us-gaap:RetainedEarningsMember2019-09-280000914025us-gaap:TreasuryStockMember2019-09-280000914025us-gaap:CommonStockMember2020-03-280000914025us-gaap:AdditionalPaidInCapitalMember2020-03-280000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-280000914025us-gaap:RetainedEarningsMember2020-03-280000914025us-gaap:TreasuryStockMember2020-03-280000914025us-gaap:RetainedEarningsMember2020-03-292020-09-260000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-292020-09-260000914025us-gaap:TreasuryStockMember2020-03-292020-09-260000914025us-gaap:CommonStockMember2019-03-300000914025us-gaap:AdditionalPaidInCapitalMember2019-03-300000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-300000914025us-gaap:RetainedEarningsMember2019-03-300000914025us-gaap:TreasuryStockMember2019-03-300000914025us-gaap:RetainedEarningsMember2019-03-312019-09-280000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-312019-09-280000914025us-gaap:CommonStockMember2019-03-312019-09-280000914025us-gaap:AdditionalPaidInCapitalMember2019-03-312019-09-280000914025us-gaap:TreasuryStockMember2019-03-312019-09-280000914025us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-09-280000914025srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-09-280000914025us-gaap:CashMember2020-09-260000914025plt:MutualFundsMemberus-gaap:FairValueInputsLevel1Member2020-09-260000914025us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2020-09-260000914025us-gaap:CashMember2020-03-280000914025plt:MutualFundsMemberus-gaap:FairValueInputsLevel1Member2020-03-28xbrli:pure0000914025plt:SeniorNotes5.50PercentMemberus-gaap:SeniorNotesMember2020-09-260000914025plt:MutualFundsMemberus-gaap:ShortTermInvestmentsMember2020-09-260000914025us-gaap:OtherNoncurrentLiabilitiesMember2020-09-260000914025us-gaap:OtherNoncurrentLiabilitiesMember2020-03-280000914025plt:ProvisionForPromotionsRebatesAndOtherMember2020-09-260000914025plt:ProvisionForPromotionsRebatesAndOtherMember2020-03-280000914025plt:ProvisionForDoubtfulAccountsAndSalesAllowancesMember2020-09-260000914025plt:ProvisionForDoubtfulAccountsAndSalesAllowancesMember2020-03-280000914025plt:PolySegmentMember2019-03-300000914025plt:ProductsSegmentMember2019-03-300000914025plt:ServicesSegmentMember2019-03-300000914025plt:PolySegmentMember2019-03-312020-03-2800009140252019-03-312020-03-280000914025plt:ProductsSegmentMember2019-03-312020-03-280000914025plt:ServicesSegmentMember2019-03-312020-03-280000914025plt:VoiceAndVideoMemberplt:PolySegmentMember2019-03-312020-03-280000914025plt:VoiceAndVideoMemberplt:ProductsSegmentMember2019-03-312020-03-280000914025plt:VoiceAndVideoMember2019-03-312020-03-280000914025plt:PolySegmentMember2020-03-280000914025plt:ProductsSegmentMember2020-03-280000914025plt:ServicesSegmentMember2020-03-280000914025plt:PolySegmentMember2020-09-260000914025plt:ProductsSegmentMember2020-09-260000914025plt:ServicesSegmentMember2020-09-26plt:unit00009140252019-03-312019-12-2800009140252019-12-292020-03-280000914025us-gaap:TechnologyBasedIntangibleAssetsMember2020-09-260000914025us-gaap:TechnologyBasedIntangibleAssetsMember2020-03-280000914025us-gaap:TechnologyBasedIntangibleAssetsMember2020-03-292020-09-260000914025us-gaap:CustomerRelationshipsMember2020-09-260000914025us-gaap:CustomerRelationshipsMember2020-03-280000914025us-gaap:CustomerRelationshipsMember2020-03-292020-09-260000914025us-gaap:TradeNamesMember2020-09-260000914025us-gaap:TradeNamesMember2020-03-280000914025us-gaap:TradeNamesMember2020-03-292020-09-2600009140252020-03-292020-06-270000914025us-gaap:LiabilityMember2020-09-260000914025us-gaap:FairValueInputsLevel2Memberplt:SeniorNotes5.50PercentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2020-09-260000914025us-gaap:FairValueInputsLevel2Memberplt:SeniorNotes5.50PercentMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2020-09-260000914025us-gaap:FairValueInputsLevel2Memberplt:SeniorNotes5.50PercentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2020-03-280000914025us-gaap:FairValueInputsLevel2Memberplt:SeniorNotes5.50PercentMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2020-03-280000914025us-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-09-260000914025us-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-09-260000914025us-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-03-280000914025us-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-03-280000914025plt:SeniorNotes5.50PercentMemberus-gaap:SeniorNotesMember2015-05-310000914025plt:SeniorNotes5.50PercentMemberus-gaap:SeniorNotesMember2015-05-012015-05-310000914025srt:MinimumMemberplt:SeniorNotes5.50PercentMemberus-gaap:SeniorNotesMember2015-05-012015-05-310000914025plt:SeniorNotes5.50PercentMembersrt:MaximumMemberus-gaap:SeniorNotesMember2015-05-012015-05-310000914025plt:SeniorNotes5.50PercentMemberus-gaap:SeniorNotesMember2020-06-282020-09-260000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2018-07-020000914025us-gaap:SecuredDebtMember2018-07-0200009140252018-07-022018-07-020000914025us-gaap:SecuredDebtMemberplt:FederalFundsRateMember2020-03-292020-09-260000914025us-gaap:SecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMember2020-03-292020-09-260000914025us-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2020-03-292020-09-260000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2020-03-292020-09-260000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-03-292020-09-260000914025plt:DebtInstrumentPeriodFebruaryTwentyTwentyTwentyThroughDecemberTwentySixTwentyTwentyMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-202020-02-200000914025us-gaap:LineOfCreditMemberplt:DebtInstrumentPeriodDecemberTwentySixTwentyTwentyandThereafterMemberus-gaap:RevolvingCreditFacilityMember2020-02-202020-02-200000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-200000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-202020-02-200000914025us-gaap:LineOfCreditMemberplt:DebtInstrumentPeriodDecemberTwentyNineTwentyNineteenThroughMarchTwentyEightTwentyTwentyMemberus-gaap:RevolvingCreditFacilityMember2020-02-200000914025us-gaap:LineOfCreditMemberplt:DebtInstrumentPeriodMarchTwentyNineTwentyTwentyThroughJuneTwentySevenTwentyTwentyMemberus-gaap:RevolvingCreditFacilityMember2020-02-200000914025plt:DebtInstrumentPeriodJuneTwentyEightTwentyTwentyThroughDecemberTwentySixTwentyTwentyMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-2000009140252020-09-262020-09-260000914025us-gaap:LineOfCreditMemberplt:TermLoanFacilityMember2020-06-282020-09-26plt:letter_of_credit0000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-09-260000914025us-gaap:EmployeeSeveranceMemberplt:FiscalYear2021RestructuringPlansMember2020-03-280000914025us-gaap:EmployeeSeveranceMemberplt:FiscalYear2021RestructuringPlansMember2020-03-292020-09-260000914025us-gaap:EmployeeSeveranceMemberplt:FiscalYear2021RestructuringPlansMember2020-09-260000914025us-gaap:FacilityClosingMemberplt:FiscalYear2021RestructuringPlansMember2020-03-280000914025us-gaap:FacilityClosingMemberplt:FiscalYear2021RestructuringPlansMember2020-03-292020-09-260000914025us-gaap:FacilityClosingMemberplt:FiscalYear2021RestructuringPlansMember2020-09-260000914025us-gaap:OtherRestructuringMemberplt:FiscalYear2021RestructuringPlansMember2020-03-280000914025us-gaap:OtherRestructuringMemberplt:FiscalYear2021RestructuringPlansMember2020-03-292020-09-260000914025us-gaap:OtherRestructuringMemberplt:FiscalYear2021RestructuringPlansMember2020-09-260000914025plt:FiscalYear2021RestructuringPlansMember2020-03-280000914025plt:FiscalYear2021RestructuringPlansMember2020-03-292020-09-260000914025plt:FiscalYear2021RestructuringPlansMember2020-09-260000914025us-gaap:EmployeeSeveranceMemberplt:FiscalYear2020RestructuringPlansMember2020-03-280000914025us-gaap:EmployeeSeveranceMemberplt:FiscalYear2020RestructuringPlansMember2020-03-292020-09-260000914025us-gaap:EmployeeSeveranceMemberplt:FiscalYear2020RestructuringPlansMember2020-09-260000914025us-gaap:FacilityClosingMemberplt:FiscalYear2020RestructuringPlansMember2020-03-280000914025us-gaap:FacilityClosingMemberplt:FiscalYear2020RestructuringPlansMember2020-03-292020-09-260000914025us-gaap:FacilityClosingMemberplt:FiscalYear2020RestructuringPlansMember2020-09-260000914025us-gaap:OtherRestructuringMemberplt:FiscalYear2020RestructuringPlansMember2020-03-280000914025us-gaap:OtherRestructuringMemberplt:FiscalYear2020RestructuringPlansMember2020-03-292020-09-260000914025us-gaap:OtherRestructuringMemberplt:FiscalYear2020RestructuringPlansMember2020-09-260000914025plt:FiscalYear2020RestructuringPlansMember2020-03-280000914025plt:FiscalYear2020RestructuringPlansMember2020-03-292020-09-260000914025plt:FiscalYear2020RestructuringPlansMember2020-09-260000914025us-gaap:EmployeeSeveranceMemberplt:FiscalYear2019RestructuringPlansMember2020-03-280000914025us-gaap:EmployeeSeveranceMemberplt:FiscalYear2019RestructuringPlansMember2020-03-292020-09-260000914025us-gaap:EmployeeSeveranceMemberplt:FiscalYear2019RestructuringPlansMember2020-09-260000914025us-gaap:FacilityClosingMemberplt:FiscalYear2019RestructuringPlansMember2020-03-280000914025us-gaap:FacilityClosingMemberplt:FiscalYear2019RestructuringPlansMember2020-03-292020-09-260000914025us-gaap:FacilityClosingMemberplt:FiscalYear2019RestructuringPlansMember2020-09-260000914025plt:FiscalYear2019RestructuringPlansMemberus-gaap:OtherRestructuringMember2020-03-280000914025plt:FiscalYear2019RestructuringPlansMemberus-gaap:OtherRestructuringMember2020-03-292020-09-260000914025plt:FiscalYear2019RestructuringPlansMemberus-gaap:OtherRestructuringMember2020-09-260000914025plt:FiscalYear2019RestructuringPlansMember2020-03-280000914025plt:FiscalYear2019RestructuringPlansMember2020-03-292020-09-260000914025plt:FiscalYear2019RestructuringPlansMember2020-09-260000914025us-gaap:EmployeeSeveranceMember2020-03-280000914025us-gaap:EmployeeSeveranceMember2020-03-292020-09-260000914025us-gaap:EmployeeSeveranceMember2020-09-260000914025us-gaap:FacilityClosingMember2020-03-280000914025us-gaap:FacilityClosingMember2020-03-292020-09-260000914025us-gaap:FacilityClosingMember2020-09-260000914025us-gaap:OtherRestructuringMember2020-03-280000914025us-gaap:OtherRestructuringMember2020-03-292020-09-260000914025us-gaap:OtherRestructuringMember2020-09-260000914025us-gaap:CostOfSalesMember2020-06-282020-09-260000914025us-gaap:CostOfSalesMember2019-06-302019-09-280000914025us-gaap:CostOfSalesMember2020-03-292020-09-260000914025us-gaap:CostOfSalesMember2019-03-312019-09-280000914025us-gaap:ResearchAndDevelopmentExpenseMember2020-06-282020-09-260000914025us-gaap:ResearchAndDevelopmentExpenseMember2019-06-302019-09-280000914025us-gaap:ResearchAndDevelopmentExpenseMember2020-03-292020-09-260000914025us-gaap:ResearchAndDevelopmentExpenseMember2019-03-312019-09-280000914025plt:SellingGeneralAndAdministrativeMember2020-06-282020-09-260000914025plt:SellingGeneralAndAdministrativeMember2019-06-302019-09-280000914025plt:SellingGeneralAndAdministrativeMember2020-03-292020-09-260000914025plt:SellingGeneralAndAdministrativeMember2019-03-312019-09-280000914025us-gaap:OperatingExpenseMember2020-06-282020-09-260000914025us-gaap:OperatingExpenseMember2019-06-302019-09-280000914025us-gaap:OperatingExpenseMember2020-03-292020-09-260000914025us-gaap:OperatingExpenseMember2019-03-312019-09-2800009140252018-11-280000914025us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-09-260000914025us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-03-280000914025us-gaap:AccumulatedTranslationAdjustmentMember2020-09-260000914025us-gaap:AccumulatedTranslationAdjustmentMember2020-03-28plt:financial_institution0000914025us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2020-09-260000914025us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2020-03-280000914025us-gaap:CashFlowHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-260000914025us-gaap:CashFlowHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-03-280000914025us-gaap:OtherCurrentAssetsMember2020-09-260000914025us-gaap:OtherCurrentAssetsMember2020-03-280000914025us-gaap:OtherLiabilitiesMemberus-gaap:NondesignatedMember2020-09-260000914025us-gaap:OtherLiabilitiesMemberus-gaap:NondesignatedMember2020-03-280000914025us-gaap:OtherLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-260000914025us-gaap:OtherLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-03-280000914025us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateSwapMember2020-09-260000914025us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateSwapMember2020-03-280000914025us-gaap:OtherLiabilitiesMember2020-09-260000914025us-gaap:OtherLiabilitiesMember2020-03-28iso4217:EUR0000914025plt:ForeignExchangeForwardEuroMember2020-09-260000914025plt:ForeignExchangeForwardEuroMember2020-03-292020-09-26iso4217:GBP0000914025plt:ForeignExchangeForwardGbpMember2020-09-260000914025plt:ForeignExchangeForwardGbpMember2020-03-292020-09-260000914025us-gaap:NondesignatedMember2020-06-282020-09-260000914025us-gaap:NondesignatedMember2019-06-302019-09-280000914025us-gaap:NondesignatedMember2020-03-292020-09-260000914025us-gaap:NondesignatedMember2019-03-312019-09-280000914025srt:MinimumMemberus-gaap:OptionMemberus-gaap:CashFlowHedgingMember2020-03-292020-09-260000914025us-gaap:OptionMemberus-gaap:CashFlowHedgingMembersrt:MaximumMember2020-03-292020-09-260000914025us-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2020-03-292020-09-260000914025us-gaap:ForeignExchangeOptionMember2020-09-260000914025us-gaap:ForeignExchangeOptionMember2020-03-280000914025us-gaap:ForeignExchangeForwardMember2020-09-260000914025us-gaap:ForeignExchangeForwardMember2020-03-280000914025us-gaap:InterestRateSwapMember2018-07-302018-07-300000914025us-gaap:InterestRateSwapMember2018-07-300000914025us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-06-282020-09-260000914025us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-06-302019-09-280000914025us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-03-292020-09-260000914025us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-03-312019-09-280000914025plt:HeadsetMember2020-06-282020-09-260000914025plt:HeadsetMember2019-06-302019-09-280000914025plt:HeadsetMember2020-03-292020-09-260000914025plt:HeadsetMember2019-03-312019-09-280000914025plt:VoiceMember2020-06-282020-09-260000914025plt:VoiceMember2019-06-302019-09-280000914025plt:VoiceMember2020-03-292020-09-260000914025plt:VoiceMember2019-03-312019-09-280000914025plt:VideoMember2020-06-282020-09-260000914025plt:VideoMember2019-06-302019-09-280000914025plt:VideoMember2020-03-292020-09-260000914025plt:VideoMember2019-03-312019-09-280000914025country:USus-gaap:ProductMember2020-06-282020-09-260000914025country:USus-gaap:ProductMember2019-06-302019-09-280000914025country:USus-gaap:ProductMember2020-03-292020-09-260000914025country:USus-gaap:ProductMember2019-03-312019-09-280000914025us-gaap:EMEAMemberus-gaap:ProductMember2020-06-282020-09-260000914025us-gaap:EMEAMemberus-gaap:ProductMember2019-06-302019-09-280000914025us-gaap:EMEAMemberus-gaap:ProductMember2020-03-292020-09-260000914025us-gaap:EMEAMemberus-gaap:ProductMember2019-03-312019-09-280000914025srt:AsiaPacificMemberus-gaap:ProductMember2020-06-282020-09-260000914025srt:AsiaPacificMemberus-gaap:ProductMember2019-06-302019-09-280000914025srt:AsiaPacificMemberus-gaap:ProductMember2020-03-292020-09-260000914025srt:AsiaPacificMemberus-gaap:ProductMember2019-03-312019-09-280000914025plt:AmericasexcludingUnitedStatesMemberus-gaap:ProductMember2020-06-282020-09-260000914025plt:AmericasexcludingUnitedStatesMemberus-gaap:ProductMember2019-06-302019-09-280000914025plt:AmericasexcludingUnitedStatesMemberus-gaap:ProductMember2020-03-292020-09-260000914025plt:AmericasexcludingUnitedStatesMemberus-gaap:ProductMember2019-03-312019-09-280000914025plt:AllCountriesExceptUnitedStatesMemberus-gaap:ProductMember2020-06-282020-09-260000914025plt:AllCountriesExceptUnitedStatesMemberus-gaap:ProductMember2019-06-302019-09-280000914025plt:AllCountriesExceptUnitedStatesMemberus-gaap:ProductMember2020-03-292020-09-260000914025plt:AllCountriesExceptUnitedStatesMemberus-gaap:ProductMember2019-03-312019-09-280000914025country:USus-gaap:ServiceMember2020-06-282020-09-260000914025country:USus-gaap:ServiceMember2019-06-302019-09-280000914025country:USus-gaap:ServiceMember2020-03-292020-09-260000914025country:USus-gaap:ServiceMember2019-03-312019-09-280000914025us-gaap:ServiceMemberus-gaap:EMEAMember2020-06-282020-09-260000914025us-gaap:ServiceMemberus-gaap:EMEAMember2019-06-302019-09-280000914025us-gaap:ServiceMemberus-gaap:EMEAMember2020-03-292020-09-260000914025us-gaap:ServiceMemberus-gaap:EMEAMember2019-03-312019-09-280000914025us-gaap:ServiceMembersrt:AsiaPacificMember2020-06-282020-09-260000914025us-gaap:ServiceMembersrt:AsiaPacificMember2019-06-302019-09-280000914025us-gaap:ServiceMembersrt:AsiaPacificMember2020-03-292020-09-260000914025us-gaap:ServiceMembersrt:AsiaPacificMember2019-03-312019-09-280000914025us-gaap:ServiceMemberplt:AmericasexcludingUnitedStatesMember2020-06-282020-09-260000914025us-gaap:ServiceMemberplt:AmericasexcludingUnitedStatesMember2019-06-302019-09-280000914025us-gaap:ServiceMemberplt:AmericasexcludingUnitedStatesMember2020-03-292020-09-260000914025us-gaap:ServiceMemberplt:AmericasexcludingUnitedStatesMember2019-03-312019-09-280000914025plt:AllCountriesExceptUnitedStatesMemberus-gaap:ServiceMember2020-06-282020-09-260000914025plt:AllCountriesExceptUnitedStatesMemberus-gaap:ServiceMember2019-06-302019-09-280000914025plt:AllCountriesExceptUnitedStatesMemberus-gaap:ServiceMember2020-03-292020-09-260000914025plt:AllCountriesExceptUnitedStatesMemberus-gaap:ServiceMember2019-03-312019-09-28plt:Customer0000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-06-282020-09-260000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberplt:ScanSourceMember2020-06-282020-09-260000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberplt:IngramMicroMember2020-06-282020-09-260000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberplt:IngramMicroMember2020-03-292020-09-260000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberplt:ScanSourceMember2020-03-292020-09-260000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2019-06-302019-09-280000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberplt:ScanSourceMember2019-06-302019-09-280000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberplt:IngramMicroMember2019-06-302019-09-280000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberplt:ScanSourceMember2019-03-312019-09-280000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberplt:IngramMicroMember2019-03-312019-09-280000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2020-09-260000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberplt:ScanSourceMember2020-03-292020-09-260000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberplt:IngramMicroMember2020-03-292020-09-260000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2020-03-280000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberplt:IngramMicroMember2019-03-312020-03-280000914025us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberplt:ScanSourceMember2019-03-312020-03-280000914025us-gaap:CustomerConcentrationRiskMemberplt:SynnexCorp.Memberus-gaap:AccountsReceivableMember2019-03-312020-03-280000914025srt:MinimumMember2020-03-292020-09-260000914025srt:MaximumMember2020-03-292020-09-26plt:segment0000914025us-gaap:OperatingSegmentsMemberplt:ProductsSegmentMember2020-06-282020-09-260000914025us-gaap:OperatingSegmentsMemberplt:ProductsSegmentMember2019-06-302019-09-280000914025us-gaap:OperatingSegmentsMemberplt:ProductsSegmentMember2020-03-292020-09-260000914025us-gaap:OperatingSegmentsMemberplt:ProductsSegmentMember2019-03-312019-09-280000914025us-gaap:OperatingSegmentsMemberplt:ServicesSegmentMember2020-06-282020-09-260000914025us-gaap:OperatingSegmentsMemberplt:ServicesSegmentMember2019-06-302019-09-280000914025us-gaap:OperatingSegmentsMemberplt:ServicesSegmentMember2020-03-292020-09-260000914025us-gaap:OperatingSegmentsMemberplt:ServicesSegmentMember2019-03-312019-09-280000914025us-gaap:OperatingSegmentsMember2020-06-282020-09-260000914025us-gaap:OperatingSegmentsMember2019-06-302019-09-280000914025us-gaap:OperatingSegmentsMember2020-03-292020-09-260000914025us-gaap:OperatingSegmentsMember2019-03-312019-09-280000914025us-gaap:MaterialReconcilingItemsMember2020-06-282020-09-260000914025us-gaap:MaterialReconcilingItemsMember2019-06-302019-09-280000914025us-gaap:MaterialReconcilingItemsMember2020-03-292020-09-260000914025us-gaap:MaterialReconcilingItemsMember2019-03-312019-09-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 26, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________to _________

Commission File Number: 001-12696

Plantronics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 77-0207692
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

345 Encinal Street
Santa Cruz, California 95060
(Address of principal executive offices)
(Zip Code)

(831) 426-5858
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value PLT New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of October 26, 2020, 41,246,609 shares of the registrant's common stock were outstanding.
1


PLT-20200926_G1.JPG

Plantronics, Inc.
FORM 10-Q
TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION Page No.
   
4
6
7
12
13
14
15
 
15
16
17
18
19
21
41
 
43
 
PART II. OTHER INFORMATION  
 
43
 
43
 
44
45
45
45
46
 
47
2



Plantronics®, Poly®, Simply Smarter Communications® , and the propeller design are trademarks or registered trademarks of Plantronics, Inc. All other trademarks are the property of their respective owners.

DECT™ is a trademark of ETSI registered for the benefit of its members in France and other jurisdictions.
The Bluetooth name and the Bluetooth® trademarks are owned by Bluetooth SIG, Inc. and are used by Plantronics, Inc. under license. All other trademarks are the property of their respective owners.
3

Table of Contents
Part I -- FINANCIAL INFORMATION

Management’s Discussion and Analysis of Financial Condition and Results of Operations

CERTAIN FORWARD-LOOKING INFORMATION:

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  These statements may generally be identified by the use of such words as "expect," "anticipate," "believe," "estimate," "intend," "predict," "project," or "will," or variations of such words and similar expressions are based on current expectations and entail various risks and uncertainties.  Specific forward-looking statements and the associated risks and uncertainties contained within this Form 10-Q include, but are not limited to: (i) our beliefs with respect to the length and severity of the COVID-19 (coronavirus) outbreak, and its impact across our businesses, our operations and global supply chain, including (a) our expectations the virus has caused and will continue to cause an increase in customer and partner demand for our product lines, including increased demand in collaboration endpoints, and our ability to design new product offerings to meet the change in demand due to a global hybrid work environment, (b) our inability to source component parts from key suppliers in sufficient quantities necessary to meet the high demand for certain product lines, including our Enterprise Headsets and continued uncertainty and potential impact on future quarters if these sourcing constraints continue and/or price volatility occurs, which could continue to negatively affect our profitability and/or market share, (c) expectations related to our voice product lines, as well as our services attachment rate for such products, which have been, and may continue to be, negatively impacted as companies have delayed returning their workforces to offices in many countries due to the continued impact of COVID-19; (d) expectations related to our ability to fulfill the backlog generated by supply constraints, to timely supply the number of products to fulfill current and future customer demand, including expectations that our manufacturing facility in Tijuana, Mexico will continue production at the capacity necessary to meet such demand, (e) the impact of the virus on our distribution partners, resellers, end-user customers and our production facilities, including our ability to obtain alternative sources of supply if our production facility or other suppliers are impacted by future shut downs, (f) the impact if global or regional economic conditions deteriorate further, on our customers and/or partners, including increased demand for pricing accommodations, delayed payments, delayed deployment plans, insolvency or other issues which may increase credit losses, (g) risks related to restrictions or delays in global return to worksites as a result of COVID-19, which continues to impact our employees worldwide and our customers, which has negatively impacted our voice product lines for the quarter, and restricted customer engagement; and (h) the complexity of the forecast analysis and the design and operation of internal controls; and (ii) our belief that we can manufacture or supply products in a timely manner to satisfy perishable demand; (iii) expectations related to our customers’ purchasing decisions and our ability to pivot quickly enough and/or match product production to demand, particularly given long lead times and the difficulty of forecasting unit volumes and acquiring the component parts and materials to meet demand without having excess inventory or incurring cancellation charges; (iv) risks associated with significant and abrupt changes in product demand which increases the complexity of management’s evaluation of potential excess or obsolete inventory; (v) risks associated with the bankruptcy or financial weakness of distributors or key customers, or the bankruptcy of or reduction in capacity of our key suppliers; (vi) risks associated with the potential interruption in the supply of sole-sourced critical components, our ability to move to a dual-source model, and the continuity of component supply at costs consistent with our plans, which has negatively impacted in the quarter and may continue to impact our ability to timely supply product to meet our customer demand; (vii) expectations related to our services segment revenues, particularly as we introduce new generation, less complex, product solutions, or as companies shift from on premises to work from home options for their workforce, which may result in decreased demand for our professional, installation and/or managed service offerings; (viii) expectations that our current cash on hand, additional cash generated from operations, together with sources of cash through our credit facility, either alone or in combination with our election to suspend our dividend payments, will meet our liquidity needs during and following the unknown duration and impact of the COVID-19 pandemic; (ix) expectations relating to our ability to generate sufficient cash flow from operations to meet our debt covenants and timely repay all principal and interest amounts drawn under our credit facility as they become due; (x) risks associated with our channel partners’ sales reporting, product inventories and product sell through since we sell a significant amount of products to channel partners who maintain their own inventory of our products; (xi) our efforts to execute to drive sales and sustainable profitable revenue growth, to improve our profitability and cash flow, and accelerate debt reduction and de-levering; (xii) our expectations for new products launches, the timing of their releases and their expected impact on future growth and on our existing products; (xiii) our belief that our Partner Program will drive growth and profitability for both us and our partners through the sale of our product, services and solutions; (xiv) risks associated with forecasting sales and procurement demands, which are inherently difficult, particularly with continuing uncertainty in regional and global economic conditions; (xv) uncertainties attributable to currency fluctuations, including fluctuations in foreign exchange rates and/or new or greater tariffs on our products; (xvi) our expectations regarding our ability to control costs, streamline operations and successfully implement our various cost-reduction activities and realize anticipated cost savings under such cost-reduction initiatives; (xvii) expectations relating to our quarterly and annual earnings guidance, particularly as economic uncertainty, including, without limitation, uncertainty related to the
4

Table of Contents
continued impact of COVID-19, the macro-economic and political climate and other external factors, puts further pressure on management judgments used to develop forward looking financial guidance and other prospective financial information; (xviii) expectations related to GAAP and non-GAAP financial results for the second quarter and full Fiscal Year 2021, including net revenues, adjusted EBITDA, tax rates, intangibles amortization, diluted weighted average shares outstanding and diluted EPS; (xix) our expectations of the impact of the acquisition of Polycom as it relates to our strategic vision and additional market and strategic partnership opportunities for our combined hardware, software and services offerings; (xx) our beliefs regarding the UC&C market, market dynamics and opportunities, and customer and partner behavior as well as our position in the market, including risks associated with the potential failure of our UC&C solutions to be adopted with the breadth and speed we anticipate; (xxi) our belief that the increased adoption of certain technologies and our open architecture approach has and will continue to increase demand for our solutions; (xxii) expectations related to the micro and macro-economic conditions in our domestic and international markets and their impact on our future business; (xxiii) our forecast and estimates with respect to tax matters, including expectations with respect to utilizing our deferred tax assets; (xxiv) our expectations related to building strategic alliances and key partnerships with providers of collaboration tools and platforms to drive revenue growth and market share; and (xxv) our expectations regarding pending and potential future litigation, in addition to other matters discussed in this Quarterly Report on Form 10-Q that are not purely historical data. Such forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially from the forward-looking statements. Factors that could cause actual results and events to differ materially from such forward-looking statements are included, but not limited to, those discussed in this Quarterly Report on Form 10-Q; in Part I, "Item 1A. Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended March 28, 2020, filed with the Securities and Exchange Commission ("SEC") on June 8, 2020; and other documents we have filed with the SEC. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.



5

Table of Contents
OVERVIEW

Plantronics, Inc. (“Poly,” “Company,” “we,” “our,” or “us”) is a leading global communications company that designs, builds, and markets collaboration solutions. Poly combines legendary audio expertise and powerful video and conferencing capabilities to create endpoints that power meaningful human connections and provide solutions that make life easier when they work together and with our partner's services. Our headsets, video and audio conferencing, desk phones, analytics software and services are used worldwide and are a leading choice for every type of home, workspace, or hybrid setting.

Our major product categories are Headsets, Video, Voice, and Services. Headsets include wired and wireless communication headsets; Voice includes open Session Initiation Protocol (“SIP”) and native ecosystem desktop phones as well as conference room phones; Video includes video conferencing solutions and peripherals, such as cameras, speakers, and microphones. Our broad portfolio of Services include video interoperability, hardware and software support for our devices, as well as professional, hosted, and managed services that are grounded in our deep expertise aimed at helping customers achieve their collaboration goals.

All of our solutions are designed to integrate seamlessly with the platform and cloud conferencing services of our strategic alliance partners, whose solutions are generally deployed to create Unified Communications & Collaboration ("UC&C"), Unified Communication as a Service ("UCaaS"), Video as a Service ("VaaS"), and/or Device as a Service ("DaaS") environments. Our cloud management and analytics software enable IT administrators to configure and update firmware, monitor device usage, troubleshoot, and gain a deeper understanding of user behaviors.

We sell our products through a well-developed global network of distributors and channel partners, including value-added resellers, integrators, direct marketing resellers, and service providers as well as through both traditional and online retailers, office supply distributors, and e-commerce channels. We have well-established distribution channels in the Americas, Europe, Middle East, Africa, and Asia Pacific where use of our products is widespread

COVID-19 Risks and Uncertainties

The novel strain of COVID-19 has continued to spread globally and continues to add uncertainty and influence global economic activity, the global supply chain and financial markets. The impact of the pandemic on our operations has varied by local conditions, government mandates and business limitations, including travel bans, remote work and other restrictions.

As a result, we continued to experience elevated demand for certain Enterprise Headsets and Video devices and a decline in demand for our Voice products, including a decline in the attachment rates for services associated with such products, as companies continued to shift from in-office to work-from-home arrangements for many of their office workers. The impact of COVID-19 is fluid and uncertain, and it has caused, and may continue to cause, various negative effects as we continue to experience periodic constraints in our supply chain, specifically the sourcing of certain components and raw materials, and increased logistics costs to meet the high customer demand for specific Headsets and Video products.

In responding to this pandemic, employee safety continues to be a critical concern to the Company and we have taken measures to protect our employees globally by adherence to public safety and shelter in place directives, physical distancing protocols within offices and manufacturing facilities, providing personal protective equipment, including face masks and hand sanitizers, conducting routine sanitation of facilities, requiring health monitoring before entry into Company facilities and restricting the number of visitors to our sites. The safety protocols implemented globally meet or exceed current regulations, however we continue to monitor employees’ safety and evolving regulatory requirements. Although our manufacturing facility remains open and certain office employees may utilize our offices when necessary, the majority of all non-factory employees continue to work from home, using headsets and other Company-issued equipment.

The full extent and duration of the impact of the COVID-19 pandemic on our business continues to be uncertain and difficult to predict and will depend on many factors outside of our control, including the extent and duration of the pandemic, mutations of the virus, the development and availability of effective treatments or vaccines, mandates of protective public safety measures, and the impact of the pandemic on the global economy, global supply chains, and demand for our products. It is not possible at this time to foresee whether the outbreak of COVID-19 or other events beyond our control will be effectively contained, nor can we estimate the entirety of the impact that COVID-19 or such other pandemics or natural or man-made disaster will have on the global economy, our business, customers, suppliers or other business partners. As such, impacts from such events to the Company are highly uncertain and the Company will continue to assess the impact from such events on our financial statements.

6

Table of Contents
Second Quarter Fiscal Year 2021 Highlights

Total net revenues for the second quarter of Fiscal Year 2021 were $411 million, a decrease of $50.7 million or 11.0% compared to the same quarter in Fiscal Year 2020, primarily driven by lower net sales in our Voice and Consumer Headset revenues partially offset by increases in Enterprise Headset and Video revenues. Refer to further discussion on total net revenues in the Results of Operations below.

Product gross margins for the second quarter of Fiscal Year 2021 were 39.8 percent, a decrease of 220 basis points compared to the same quarter in Fiscal Year 2020, primarily driven by increases in logistics costs and factory capacity expansion for Headset and Video products. These unfavorable impacts were partially offset by changes in our product mix to higher margin Headset and Video products.

We repurchased $37.4 million of our outstanding debt, including $30 million of the Term B facility and $7.4 million of our 5.50% senior notes during the second quarter of Fiscal Year 2021.



RESULTS OF OPERATIONS

We group our operations into two reportable segments: Products and Services. Our Products segment consists of Headsets, Voice, and Video product categories and our Services segment consists of support, professional, managed, and cloud services and solutions.

NET REVENUES

The following table sets forth net revenues by reportable segment for the three and six months ended September 26, 2020 and September 28, 2019:

Three Months Ended Six Months Ended
(in thousands, except percentages) September 26, 2020 September 28, 2019 Change September 26, 2020 September 28, 2019 Change
Net revenues
Products $ 347,677  $ 395,137  $ (47,460) (12.0) % $ 639,135  $ 777,882  $ (138,747) (17.8) %
Services 63,292  66,572  (3,280) (4.9) % 127,554  131,594  (4,040) (3.1) %
Total net revenues $ 410,969  $ 461,709  $ (50,740) (11.0) % $ 766,689  $ 909,476  $ (142,787) (15.7) %

Products

Net products revenues decreased in the three and six months ended September 26, 2020 compared to the prior year periods, primarily due to the following:

Voice product revenues declined as a result of the COVID-19 shift in demand toward "work from home" products.
Consumer Headsets declined significantly year over year primarily due to our decision to discontinue certain low-margin mono and stereo products and the sale of our gaming headset assets in the fiscal fourth quarter of FY20.
Partially offsetting the declines in Voice and Consumer, was growth in Enterprise Headset and Video net revenues driven by the COVID-19 shift toward "work from home" and the need for office workers to be able to effectively communicate and collaborate regardless of location. Although we continue to experience periodic supply constraints on certain headsets and new video products, we were able to ship a record number of headsets and video units during the quarter, Video demand was also driven by remote learning, telemedicine, and the continued ramp of our new video portfolio.

Services

Net revenues decreased slightly in the three and six months ended September 26, 2020 in our Support Services category due to the Video product mix shift from legacy Platform and Telepresence to recently launched Studio video bars, which are less complex, easier to install and operate, and carry optional service contracts. The decrease was mostly offset by the impact of the deferred revenue fair value adjustment resulting from the Polycom Acquisition.
7

Table of Contents
The following table sets forth net revenues by geographic region for the three and six months ended September 26, 2020 and September 28, 2019:

Three Months Ended Six Months Ended
(in thousands, except percentages) September 26, 2020 September 28, 2019 Change September 26, 2020 September 28, 2019 Change
Net revenues
U.S. $ 183,777  $ 213,127  $ (29,350) (13.8) % $ 352,058  $ 437,954  $ (85,896) (19.6) %
Europe and Africa 130,399  128,973  1,426  1.1  % 224,505  245,952  (21,447) (8.7) %
Asia Pacific 71,569  87,453  (15,884) (18.2) % 135,833  162,301  (26,468) (16.3) %
Americas, excluding U.S. 25,224  32,156  (6,932) (21.6) % 54,293  63,269  (8,976) (14.2) %
Total international net revenues 227,192  248,582  (21,390) (8.6) % 414,631  471,522  (56,891) (12.1) %
Total net revenues $ 410,969  $ 461,709  $ (50,740) (11.0) % $ 766,689  $ 909,476  $ (142,787) (15.7) %

United States (U.S.)

Compared to the same prior year period, U.S. net revenues for the three and six months ended September 26, 2020 decreased primarily due to declines in our Voice product revenues; a result of COVID-19 shift in demand toward "work from home" products. Our Consumer Headset product revenues declined driven by our decision to eliminate lower margin consumer products from our portfolio, including the Fiscal Year 2020 sale of gaming headset assets. Sales of our Enterprise Headset products declined slightly primarily due to a shift in product demand to UC&C products where we have experienced some supply shortages of component parts. These declines were partially offset by growth in our Video product revenues as new products ramp.

International

International net revenues for the three and six months ended September 26, 2020 decreased from the same prior year period primarily due to declines in Voice and Consumer Headset product revenues. These declines were partially offset by an increase in our Enterprise Headset product revenues.

During the three months ended September 26, 2020, changes in foreign exchange rates unfavorably impacted net revenues by $7.1 million, net of the effects of hedging, compared to a $3.8 million unfavorable impact on revenue in the prior year period.

During the six months ended September 26, 2020, changes in foreign exchange rates unfavorably impacted net revenues by $4.7 million, net of the effects of hedging, compared to a $7.7 million unfavorable impact on revenue in the prior year period.


8

Table of Contents
COST OF REVENUES AND GROSS PROFIT

Cost of revenues consists primarily of direct and contract manufacturing costs, amortization of acquired technology, freight, warranty, charges for excess and obsolete inventory, depreciation, duties, royalties, and overhead expenses. 
  Three Months Ended Six Months Ended
(in thousands, except percentages) September 26, 2020 September 28, 2019 Change September 26, 2020 September 28, 2019 Change
Products:
Net revenues $ 347,677  $ 395,137  $ (47,460) (12.0) % $ 639,135  $ 777,882  $ (138,747) (17.8) %
Cost of revenues 209,261  229,323  (20,062) (8.7) % 385,876  437,939  (52,063) (11.9) %
Gross profit $ 138,416  $ 165,814  $ (27,398) (16.5) % $ 253,259  $ 339,943  $ (86,684) (25.5) %
Gross profit % 39.8  % 42.0  % 39.6  % 43.7  %
Services:
Net revenues $ 63,292  $ 66,572  $ (3,280) (4.9) % $ 127,554  $ 131,594  $ (4,040) (3.1) %
Cost of revenues 20,962  26,315  (5,353) (20.3) % 43,735  52,820  (9,085) (17.2) %
Gross profit $ 42,330  $ 40,257  $ 2,073  5.1  % $ 83,819  $ 78,774  $ 5,045  6.4  %
Gross profit % 66.9  % 60.5  % 65.7  % 59.9  %
Total:
Net revenues $ 410,969  $ 461,709  $ (50,740) (11.0) % $ 766,689  $ 909,476  $ (142,787) (15.7) %
Cost of revenues 230,223  255,638  (25,415) (9.9) % 429,611  490,759  (61,148) (12.5) %
Gross profit $ 180,746  $ 206,071  $ (25,325) (12.3) % $ 337,078  $ 418,717  $ (81,639) (19.5) %
Gross profit % 44.0  % 44.6  % 44.0  % 46.0  %

Products

Compared to the prior year period, gross profit as a percentage of net revenues decreased in the three months ended September 26, 2020, primarily due to COVID-19 related incremental manufacturing and logistics costs, fixed cost items spread over lower net revenues, and Video and Voice product transitions. Partially offsetting these unfavorable items was a decrease in intangible asset amortization expense resulting from the long-lived asset impairment of existing technology related to our Voice products in the fourth quarter of Fiscal Year 2020 and a favorable product mix.

Compared to the prior year period, gross profit as a percentage of net revenues decreased in the six months ended September 26, 2020, primarily due to COVID-19 related incremental manufacturing and logistics costs and fixed cost items spread over lower net revenues. Partially offsetting these unfavorable items was a decrease in intangible asset amortization expense resulting from the long-lived asset impairment of existing technology related to our Voice products in the fourth quarter of Fiscal Year 2020 and favorable product mix.

Given the significant variances in gross profit percentages between our higher and lower margin products, gross profit percentages may be impacted by variations in product mix and other factors, including production levels, distribution channels, and return rates.

Services

Compared to the prior year period, the gross profit as a percentage of net revenues increased in the three and six months ended September 26, 2020, primarily due to the decrease in the Polycom acquisition-related deferred revenue fair value adjustment and a lower fixed cost base.




9

Table of Contents
OPERATING EXPENSES

Operating expenses for the three and six months ended September 26, 2020 and September 28, 2019 were as follows:
  Three Months Ended Six Months Ended
(in thousands, except percentages) September 26, 2020 September 28, 2019 Change September 26, 2020 September 28, 2019 Change
Research, development, and engineering $ 52,148  $ 57,415  $ (5,267) (9.2) % $ 102,177  $ 116,939  $ (14,762) (12.6) %
Selling, general and administrative 115,605  148,419  (32,814) (22.1) % 232,250  312,027  (79,777) (25.6) %
(Gain) loss, net from litigation settlements —  —  —  —  % 17,561  (1,162) 18,723  1,611.3  %
Restructuring and other related charges 6,170  5,847  323  5.5  % 35,500  25,372  10,128  39.9  %
Total Operating Expenses $ 173,923  $ 211,681  $ (37,758) (17.8) % $ 387,488  $ 453,176  $ (65,688) (14.5) %
% of net revenues 42.3  % 45.8  % 50.5  % 49.8  %

Research, development, and engineering expenses decreased during the three and six months ended September 26, 2020 when compared to the prior year period primarily due to lower compensation expense driven by reduction in headcount, cost control efforts, and decreased expenses due to COVID-19 restrictions.

Selling, general and administrative expenses decreased during the three months ended September 26, 2020 when compared to the prior year period primarily due to lower compensation expense driven by reduced headcount, cost control efforts, and decreased travel expenses due to COVID-19 restrictions. The decreases were partially offset by higher incentive compensation when compared to the prior year period. Selling, general and administrative expenses decreased during the six months ended September 26, 2020 when compared to the prior year period primarily due to integration related expenses that did not occur in the current period, lower compensation expense, driven by reduced headcount and lower sales commissions, decreased expenses due to COVID-19 restrictions, and other cost control efforts.

During the six months ended September 26, 2020 we recorded litigation charges for settlements that occurred during the period. See Note 7, Commitments and Contingencies, of the accompanying notes to condensed consolidated financial statements for further information regarding on-going litigation.

Compared to the prior year period, restructuring and other related charges increased in the six months ended September 26, 2020, primarily due to restructuring actions initiated during the period to reduce expenses and optimize our cost structure and align with projected revenue levels. These actions consisted of headcount reductions and office closures. For more information regarding restructuring activities, see Note 9, Restructuring and Other Related Charges, of the accompanying notes to condensed consolidated financial statements.

INTEREST EXPENSE

Interest expense for the three and six months ended September 26, 2020 and September 28, 2019 was as follows:
  Three Months Ended Six Months Ended
(in thousands, except percentages) September 26, 2020 September 28, 2019 Change September 26, 2020 September 28, 2019 Change
Interest expense $ (18,581) $ (23,797) $ 5,216  21.9  % $ (39,765) $ (47,729) $ 7,964  16.7  %
% of net revenues (4.5) % (5.2) % (5.2) % (5.2) %

Interest expense decreased for the three and six months ended September 26, 2020 primarily due to a lower outstanding balance on the term loan facility, the gains recognized on the repurchase of outstanding debt, and lower interest rates. See Note 8, Debt, of the accompanying notes to condensed consolidated financial statements.

10

Table of Contents
OTHER NON-OPERATING INCOME, NET

Other non-operating income, net for the three and six months ended September 26, 2020 and September 28, 2019 was as follows:
  Three Months Ended Six Months Ended
(in thousands, except percentages) September 26, 2020 September 28, 2019 Change September 26, 2020 September 28, 2019 Change
Other non-operating income (loss), net $ 1,366  $ (625) $ 1,991  (318.6) % $ 1,592  $ (292) $ 1,884  (645.2) %
% of net revenues 0.3  % (0.1) % 0.2  % —  %

Other non-operating income, net for the three and six months ended September 26, 2020 increased primarily due to immaterial net foreign currency gains and immaterial unrealized gains on the deferred compensation portfolio during the current period compared to immaterial net foreign currency losses in the prior period.

INCOME TAX BENEFIT
  Three Months Ended Six Months Ended
(in thousands except percentages) September 26, 2020 September 28, 2019 Change September 26, 2020 September 28, 2019 Change
Loss before income taxes $ (10,392) $ (30,032) $ 19,640  65.4  % $ (88,583) $ (82,480) $ (6,103) (7.4) %
Income tax expense (benefit) 3,013  (4,122) 7,135  173.1  % (163) (11,699) 11,536  98.6  %
Net loss $ (13,405) $ (25,910) $ 12,505  48.3  % $ (88,420) $ (70,781) $ (17,639) (24.9) %
Effective tax rate (29.0) % 13.7  % 0.2  % 14.2  %

The Company and its subsidiaries are subject to taxation in the U.S. and in various foreign and state jurisdictions. Our income tax expense or benefit is determined using an estimate of our annual effective tax rate and adjusted for discrete items that are taken into account in the relevant period. The effective tax rates for the three months ended September 26, 2020 and September 28, 2019 were (29.0)% and 13.7%, respectively. The effective tax rates for the six months ended September 26, 2020 and September 28, 2019 were 0.2% and 14.2%, respectively.

The change in our effective tax rate for the three and six months ended September 26, 2020 relative to the prior year is primarily due to a benefit from internal intangible property restructuring between our wholly-owned subsidiaries to better align the IP structure to our evolving operations.

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss incurred over the two-year period ended March 28, 2020 and Fiscal Year 2021 forecasted results in the U.S. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth. On the basis of this evaluation, as of September 26, 2020, a valuation allowance against U.S. federal and state deferred tax assets continues to be maintained for the three months ended September 26, 2020.

As of September 26, 2020, we had approximately $86.3 million in non-US net deferred tax assets ("DTAs") after valuation allowance. A significant portion of our DTAs relate to internal intangible property restructuring between wholly-owned subsidiaries. At this time, based on evidence currently available, we consider it more likely than not that we will have sufficient taxable income in the future that will allow us to realize our DTAs; however, failure to generate sufficient future taxable income could result in some or all DTAs not being utilized in the future. If we are unable to generate sufficient future taxable income, a substantial valuation allowance to reduce our DTAs may be required.

11

Table of Contents
FINANCIAL CONDITION

Liquidity and Capital Resources

The following tables present selected financial information and statistics as of September 26, 2020 and March 28, 2020 and for the first six months of Fiscal Years 2021 and 2020 (in thousands):
September 26, 2020 March 28, 2020
Cash, cash equivalents, and short-term investments $ 227,876  $ 225,720 
Property, plant and equipment, net $ 150,348  $ 165,858 
Long-term debt, net of issuance costs $ 1,587,556  $ 1,621,694 
Working capital $ 193,057  $ 209,203 
Six Months Ended
September 26, 2020 September 28, 2019
Cash provided by operating activities $ 40,257  $ 33,566 
Cash used for investing activities $ (9,219) $ (7,754)
Cash used for financing activities $ (32,881) $ (39,587)

Our cash and cash equivalents as of September 26, 2020 consisted of bank deposits with third party financial institutions. We monitor bank balances in our operating accounts and adjust the balances as appropriate. Cash balances are held throughout the world, including substantial amounts held outside of the U.S. As of September 26, 2020, of our $227.9 million of cash, cash equivalents, and short-term investments, $129.4 million was held domestically while $98.5 million was held by foreign subsidiaries, and approximately 73% was based in USD-denominated instruments. Our remaining investments were composed of Mutual Funds.

During the six months ended September 26, 2020, cash generated by operating activities of $40.3 million was a result of $88.4 million of net loss, non-cash adjustments to net loss of $119.6 million and an increase in the net change in operating assets and liabilities of $9.1 million. Cash used in investing activities of $(9.2) million during the six months ended September 26, 2020 consisted primarily of cash used to acquire property, plant and equipment of $10.9 million and partially offset by proceeds from assets held for sales of $1.9 million. Cash used in financing activities of $(32.9) million during the six months ended September 26, 2020 consisted primarily of $35.6 million repayment of long-term debt and $3.0 million for taxes paid on behalf of employees related to net share settlements of vested employee equity awards. The uses of cash were partially offset by $5.7 million of proceeds from issuance of common stock from our Employee Stock Purchase Plan ("ESPP").

During the six months ended September 28, 2019, cash generated by operating activities of $33.6 million was a result of $70.8 million of net loss, non-cash adjustments to net loss of $117.3 million and a decrease in the net change in operating assets and liabilities of $12.9 million. Cash used in investing activities of $(7.8) million during the six months ended September 28, 2019 consisted primarily of cash used to acquire property, plant and equipment of $9.3 million partially offset by proceeds from the sale of real property of $2.1 million. Cash used in financing activities of $(39.6) million during the six months ended September 28, 2019 consisted primarily of early repayment of long-term debt of $25.0 million, payment of the quarterly dividend on our common stock of $11.9 million, and taxes paid on behalf of employees related to net share settlements of vested employee equity awards of $9.3 million. The uses of cash were partially offset by proceeds from issuance of common stock from our Employee Stock Purchase Plan ("ESPP") of $6.6 million.

Debt

In July 2018, in connection with the Acquisition, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto and borrowed the full amount available under the term loan facility of $1.245 billion, net of approximately $30 million of discounts and issuance costs. During the second quarter of Fiscal Year 2021, we repurchased $30.0 million of our outstanding principal and recorded an immaterial gain on the extinguishment of debt. As of September 26, 2020, we had $1.099 billion of the term loan outstanding.

On February 20, 2020, we entered into an Amendment No. 2 to the Credit Agreement (the “Amendment”) in order to relax certain financial covenants on the revolving line of credit. The financial covenants under the Credit Agreement are for the
12

Table of Contents
benefit of the revolving credit lenders only and do not apply to any other debt of the Company. As of September 26, 2020, the Company has five outstanding letters of credit on the revolving credit facility for a total of $1.4 million and had $98.6 million available under the revolving line of credit. As of September 26, 2020, the Company was in compliance with the financial covenants.

On July 30, 2018, we entered into a 4-year amortizing interest rate swap agreement with Bank of America, N.A. The swap has an initial notional amount of $831 million and matures on July 31, 2022. During the six months ended September 26, 2020, the Company reclassified into interest expense $7.3 million and recorded a $15.9 million unrealized loss on its interest rate swap derivative designated as a cash flow hedge.

During Fiscal Year 2016, we obtained $488.4 million from debt financing, net of issuance costs. The debt matures on May 31, 2023 and bears interest at an annual rate of 5.50%. During the second quarter of Fiscal Year 2021 we repurchased $7.4 million of our outstanding principal and recorded an immaterial gain on the extinguishment of debt. As of September 26, 2020, we had $488.8 million of debt outstanding.

We may at any time and from time to time, depending on market conditions and prices, continue to retire or purchase our outstanding debt through cash purchases and/or exchanges for equity or debt, in open-market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will be upon such terms and at such prices as we may determine, and will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.

Further information regarding the Company’s debt issuances and related hedging activity can be found in Note 8, Debt and Note 13, Derivatives, of the accompanying notes to condensed consolidated financial statements.

Capital Return Program

On November 28, 2018, the Board approved a 1 million share repurchase program expanding our capacity to repurchase shares to approximately 1.7 million shares. During the first half of Fiscal Year 2021, we did not repurchase any shares of our common stock. As of September 26, 2020, there remained 1,369,014 shares authorized for repurchase under the existing stock repurchase program. See Note 11, Common Stock Repurchases, of the accompanying notes to condensed consolidated financial statements.

We believe that our current cash and cash equivalents, short-term investments, cash provided by operations, and availability of additional funds under the Credit Agreement, as amended from time to time, will be sufficient to fund our operations. However, any projections of future financial needs and sources of working capital are subject to uncertainty on our financial results. Readers are cautioned to review the risks, uncertainties, and assumptions set forth in this Quarterly Report on Form 10-Q, including the section entitled "Certain Forward-Looking Information" and the risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended March 28, 2020, filed with the SEC on June 8, 2020, and other periodic filings with the SEC, any of which could affect our estimates for future financial needs and sources of working capital.

OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, derivative instruments, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides us with financing and liquidity support, market risk, or credit risk support.

Consigned Inventory

A substantial portion of the raw materials, components, and subassemblies used in our products are provided by our suppliers on a consignment basis. These consigned inventories are not recorded on our consolidated balance sheet until we take title to the raw materials, components, and subassemblies, which occurs when they are consumed in the production process. Prior to consumption in the production process, our suppliers bear the risk of loss and retain title to the consigned inventory. The agreements allow us to return parts in excess of maximum order quantities to the suppliers at the supplier’s expense. Returns for other reasons are negotiated with the suppliers on a case-by-case basis and to date have been immaterial. If our suppliers were to discontinue financing consigned inventory, it would require us to make cash outlays and we could incur expenses which, if material, could negatively affect our business and financial results. As of September 26, 2020, and March 28, 2020, we had off-balance sheet consigned inventories of $42.1 million and $21.7 million, respectively.

13

Table of Contents
Unconditional Purchase Obligations

We use several contract manufacturers to manufacture raw materials, components, and subassemblies for our products through our supply of demand information that typically covers periods up to 13 weeks. The contract manufacturers use this information to acquire components and build products. We also obtain individual components for our products from a wide variety of individual suppliers using a combination of purchase orders, supplier contracts, including annual minimum purchase obligations, and open orders based on projected demand information. As of September 26, 2020, we had outstanding off-balance sheet third-party manufacturing, component purchase, and other general and administrative commitments of $420.4 million, including the off-balance sheet consigned inventories of $42.1 million.

Except as described above, there have been no material changes in our contractual obligations as described in our Annual Report on Form 10-K for the fiscal year ended March 28, 2020.

CRITICAL ACCOUNTING ESTIMATES

For a complete description of what we believe to be the critical accounting estimates used in the preparation of our condensed consolidated financial statements, refer to our Annual Report on Form 10-K for the fiscal year ended March 28, 2020, filed with the SEC on June 8, 2020. There have been no material changes to our critical accounting estimates during the six months ended September 26, 2020.

Recent Accounting Pronouncements

For more information regarding the Recent Accounting Pronouncements that may impact us, see Note 2, Recent Accounting Pronouncements, of the accompanying notes to the condensed consolidated financial statements.
14

Table of Contents
Financial Statements (Unaudited)
PLANTRONICS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(Unaudited)
September 26, 2020 March 28,
2020
ASSETS    
Current assets:    
Cash and cash equivalents $ 213,901  $ 213,879 
Short-term investments 13,975  11,841 
Accounts receivable, net 239,479  246,835 
Inventory, net 183,636  164,527 
Other current assets 51,987  47,946 
Total current assets 702,978  685,028 
Property, plant, and equipment, net 150,348  165,858 
Goodwill 796,216  796,216 
Purchased intangibles, net 403,110  466,915 
Deferred tax assets 86,790  82,496 
Other assets 62,101  60,661 
Total assets $ 2,201,543  $ 2,257,174 
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Current liabilities:    
Accounts payable $ 136,463  $ 102,159 
Accrued liabilities 373,458  373,666 
Total current liabilities 509,921  475,825 
Long term debt, net of issuance costs 1,587,556  1,621,694 
Long-term income taxes payable 91,235  98,319 
Other long-term liabilities 157,836  144,152 
Total liabilities 2,346,548  2,339,990 
Commitments and contingencies (Note 7)
Stockholders' deficit:    
Common stock 907  896 
Additional paid-in capital 1,526,677  1,501,340 
Accumulated other comprehensive loss (9,650) (13,582)
Accumulated deficit (796,324) (707,904)
Total stockholders' equity before treasury stock 721,610  780,750 
Less:  Treasury stock, at cost (866,615) (863,566)
Total stockholders' deficit (145,005) (82,816)
Total liabilities and stockholders' deficit $ 2,201,543  $ 2,257,174 

The accompanying notes are an integral part of these condensed consolidated financial statements.
15

Table of Contents
PLANTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(Unaudited)
Three Months Ended Six Months Ended
  September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Net revenues
Net product revenues $ 347,677  $ 395,137  $ 639,135  $ 777,882 
Net service revenues 63,292  66,572  127,554  131,594 
Total net revenues 410,969  461,709  766,689  909,476 
Cost of revenues
Cost of product revenues 209,261  229,323  385,876  437,939 
Cost of service revenues 20,962  26,315  43,735  52,820 
Total cost of revenues 230,223  255,638  429,611  490,759 
Gross profit 180,746  206,071  337,078  418,717 
Operating expenses:
Research, development, and engineering 52,148  57,415  102,177  116,939 
Selling, general, and administrative 115,605  148,419  232,250  312,027 
(Gain) loss, net from litigation settlements —  —  17,561  (1,162)
Restructuring and other related charges 6,170  5,847  35,500  25,372 
Total operating expenses 173,923  211,681  387,488  453,176 
Operating income (loss) 6,823  (5,610) (50,410) (34,459)
Interest expense (18,581) (23,797) (39,765) (47,729)
Other non-operating income (loss), net 1,366  (625) 1,592  (292)
Loss before income taxes (10,392) (30,032) (88,583) (82,480)
Income tax expense (benefit) 3,013  (4,122) (163) (11,699)
Net loss $ (13,405) $ (25,910) $ (88,420) $ (70,781)
Loss per common share:
Basic $ (0.33) $ (0.65) $ (2.17) $ (1.80)
Diluted $ (0.33) $ (0.65) $ (2.17) $ (1.80)
Shares used in computing loss per common share:
Basic 40,970  39,584  40,715  39,411 
Diluted 40,970  39,584  40,715  39,411 

The accompanying notes are an integral part of these condensed consolidated financial statements.




16

Table of Contents
PLANTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)
(Unaudited)
Three Months Ended Six Months Ended
September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Net loss $ (13,405) $ (25,910) $ (88,420) $ (70,781)
Other comprehensive income (loss):
Foreign currency translation adjustments —  —  —  (219)
Unrealized gains (losses) on cash flow hedges:
Unrealized cash flow hedge gains (losses) arising during the period (3,006) 2,369  (4,585) (4,335)
Net (gains) losses reclassified into income for revenue hedges 1,652  (1,568) 743  (2,927)
Net (gains) losses reclassified into income for cost of revenue hedges —  (62) —  (166)
Net (gains) losses reclassified into income for interest rate swaps 3,528  945  7,251  1,597 
Net unrealized gains (losses) on cash flow hedges 2,174  1,684  3,409  (5,831)
Aggregate income tax benefit (expense) of the above items 259  (434) 523  1,147 
Other comprehensive income (loss) 2,433  1,250  3,932  (4,903)
Comprehensive loss $ (10,972) $ (24,660) $ (84,488) $ (75,684)

The accompanying notes are an integral part of these condensed consolidated financial statements.




17

Table of Contents

PLANTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
Six Months Ended
  September 26, 2020 September 28, 2019
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (88,420) $ (70,781)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization 84,371  115,074 
Amortization of debt issuance costs 2,660  2,722 
Stock-based compensation 19,618  27,597 
Deferred income taxes (4,056) (45,067)
Provision for excess and obsolete inventories 9,158  5,682 
Restructuring and related charges 35,500  25,372 
Cash payments for restructuring charges (24,459) (22,949)
Other operating activities (3,162) 8,894 
Changes in assets and liabilities, net of acquisition:  
Accounts receivable, net 7,627  3,778 
Inventory, net (27,550) (55,584)
Current and other assets (5,945) 9,352 
Accounts payable 32,892  34,910 
Accrued liabilities 23,025  (31,694)
Income taxes (21,002) 26,260 
Cash provided by operating activities 40,257  33,566 
CASH FLOWS FROM INVESTING ACTIVITIES  
Proceeds from sales of investments —  170 
Purchase of investments (238) (806)
Capital expenditures (10,881) (9,260)
Proceeds from sale of property and equipment 1,900  2,142 
Cash used for investing activities (9,219) (7,754)
CASH FLOWS FROM FINANCING ACTIVITIES  
Employees' tax withheld and paid for restricted stock and restricted stock units (3,049) (9,281)
Proceeds from issuances under stock-based compensation plans 5,731  6,616 
Proceeds from revolving line of credit 50,000  — 
Repayments of revolving line of credit (50,000) — 
Payment of cash dividends —  (11,922)
Repayments of long-term debt (35,563) (25,000)
Cash used for financing activities (32,881) (39,587)
Effect of exchange rate changes on cash and cash equivalents 1,865  (2,292)
Net increase (decrease) in cash and cash equivalents 22  (16,067)
Cash and cash equivalents at beginning of period 213,879  202,509 
Cash and cash equivalents at end of period $ 213,901  $ 186,442 
SUPPLEMENTAL DISCLOSURES
Cash paid for income taxes $ 23,204  $ 5,836 
Cash paid for interest $ 38,415  $ 39,777 

The accompanying notes are an integral part of these condensed consolidated financial statements.
18

Table of Contents

PLANTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) / EQUITY
(in thousands)
(Unaudited)
Three Months Ended September 26, 2020
  Common Stock Additional Paid-In Accumulated Other Comprehensive Retained Treasury Total Stockholders'
  Shares Amount Capital Loss Earnings Stock Deficit
Balances at June 27, 2020 40,682  $ 901  $ 1,510,695  $ (12,083) $ (782,919) $ (866,305) $ (149,711)
Net loss —  —  —  —  (13,405) —  (13,405)
Net unrealized gains (losses) on cash flow hedges, net of tax —  —  —  2,433  —  —  2,433 
Proceeds from issuances under stock-based compensation plans 129  —  —  —  — 
Stock-based compensation —  —  10,263  —  —  —  10,263 
Employees' tax withheld and paid for restricted stock and restricted stock units (22) —  —  —  —  (310) (310)
Proceeds from ESPP 457  5,719  —  —  —  5,724 
Other equity changes —  —  —  —  —  —  — 
Balances at September 26, 2020 41,246  $ 907  $ 1,526,677  $ (9,650) $ (796,324) $ (866,615) $ (145,005)
Three Months Ended September 28, 2019
  Common Stock Additional Paid-In Accumulated Other Comprehensive Retained Treasury Total Stockholders'
  Shares Amount Capital Loss Earnings Stock Equity
Balances at June 29, 2019 39,578  $ 887  $ 1,445,097  $ (6,628) $ 92,437  $ (862,295) $ 669,498 
Net loss —  —  —  —  (25,910) —  (25,910)
Net unrealized gains (losses) on cash flow hedges, net of tax —  —  —  1,277  —  —  1,277 
Proceeds from issuances under stock-based compensation plans 101  165  —  —  —  166 
Repurchase of restricted common stock (9) —  —  —  —  —  — 
Cash dividends —  —  —  —  (5,982) —  (5,982)
Stock-based compensation —  —  14,693  —  —  —  14,693 
Employees' tax withheld and paid for restricted stock and restricted stock units (21) —  —  —  —  (660) (660)
Proceeds from ESPP 268  6,023  —  —  —  6,025 
Balances at September 28, 2019 39,917  $ 890  $ 1,465,978  $ (5,351) $ 60,545  $ (862,955) $ 659,107 

Six Months Ended September 26, 2020
  Common Stock Additional Paid-In Accumulated Other Comprehensive Retained Treasury Total Stockholders'
  Shares Amount Capital Loss Earnings Stock Deficit
Balances at March 28, 2020 $ 40,406  $ 896  $ 1,501,340  $ (13,582) $ (707,904) $ (863,566) $ (82,816)
Net loss —  —  —  —  (88,420) —  (88,420)
Net unrealized gains (losses) on cash flow hedges, net of tax —  —  —  3,932  —  —  3,932 
Proceeds from issuances under stock-based compensation plans 648  —  —  —  — 
Repurchase of restricted common stock (10) —  —  —  —  —  — 
Stock-based compensation —  —  19,618  —  —  —  19,618 
Employees' tax withheld and paid for restricted stock and restricted stock units (255) —  —  —  —  (3,049) (3,049)
Proceeds from ESPP 457  5,719  —  —  —  5,724 
Other equity changes —  —  —  —  —  —  — 
Balances at September 26, 2020 $ 41,246  $ 907  $ 1,526,677  $ (9,650) $ (796,324) $ (866,615) $ (145,005)
19

Table of Contents
Six Months Ended September 28, 2019
  Common Stock Additional Paid-In Accumulated Other Comprehensive Retained Treasury Total Stockholders'
  Shares Amount Capital Loss Earnings Stock Equity
Balances at March 30, 2019 $ 39,518  $ 884  $ 1,431,607  $ (475) $ 143,344  $ (853,673) $ 721,687 
Net loss —  —  —  —  (70,781) —  (70,781)
Foreign currency translation adjustments —  —  —  (219) —  —  (219)
Net unrealized gains (losses) on cash flow hedges, net of tax —  —  —  (4,657) —  —  (4,657)
Proceeds from issuances under stock-based compensation plans 372  751  —  —  —  755 
Repurchase of restricted common stock (29) —  —  —  —  —  — 
Cash dividends —  —  —  —  (11,922) —  (11,922)
Stock-based compensation —  —  27,597  —  —  —  27,597 
Employees' tax withheld and paid for restricted stock and restricted stock units (212) —  —  —  —  (9,282) (9,282)
Proceeds from ESPP 268  6,023  —  —  —  6,025 
Impact of new accounting standards adoption —  —  —  —  (89) —  (89)
Other equity changes —  —  —  —  (7) —  (7)
Balances at September 28, 2019 $ 39,917  $ 890  $ 1,465,978  $ (5,351) $ 60,545  $ (862,955) $ 659,107 

The accompanying notes are an integral part of these condensed consolidated financial statements.
20

Table of Contents
PLANTRONICS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. BASIS OF PRESENTATION

In the opinion of management, the accompanying unaudited condensed consolidated financial statements ("financial statements") of Plantronics, Inc. ("the Company") have been prepared on a basis materially consistent with the Company's March 28, 2020 audited consolidated financial statements and include all adjustments, consisting of normal recurring adjustments, necessary to fairly state the information set forth herein. Certain information and footnote disclosures normally included in financial statements prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") applicable to interim financial information and in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 28, 2020, which was filed with the SEC on June 8, 2020. The results of operations for the interim period ended September 26, 2020 are not necessarily indicative of the results to be expected for the entire fiscal year or any future period.

The financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.

The Company’s fiscal year ends on the Saturday closest to the last day of March. The Company’s current and prior fiscal years end on March 27, 2021 and March 28, 2020, respectively, and both consist of 52 weeks. The Company’s results of operations for the three and six months ended September 26, 2020 and September 28, 2019 both contain 13 weeks.

Risks and uncertainties

As described in the Company's Annual Report on Form 10-K for the fiscal year ended March 28, 2020, which was filed with the SEC on June 8, 2020, the Company is subject to a greater degree of uncertainty than normal in making the judgments and estimates needed to apply its significant accounting policies as a result of the COVID-19 pandemic. The Company continues to assess various accounting estimates and other matters in context to the unknown future impacts of COVID-19 using information that is reasonably available as of the issuance date of the condensed consolidated financial statements. The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on its customers and suppliers, all of which are uncertain and cannot be predicted. As of the date of issuance of these condensed consolidated financial statements, the extent to which the pandemic may materially impact the Company's financial condition, liquidity, or results of operations is uncertain.

Reclassifications

Certain prior year amounts have been reclassified for consistency with current year presentation. Each of the reclassifications was immaterial and had no effect on the Company's results of operations.

2. RECENT ACCOUNTING PRONOUNCEMENTS

Recently Adopted Pronouncement

In June 2016, the Financial Accounting Standards Board ("FASB") issued guidance regarding the measurement of credit losses on financial instruments, which changes the impairment model for most financial assets. The new model uses a forward-looking expected loss method, which will generally result in earlier recognition of allowances for losses. The Company adopted the new standard effective March 29, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption had an immaterial impact on the Company’s financial position, results of operations or cash flows.

21

3. CASH, CASH EQUIVALENTS, AND INVESTMENTS

The following tables summarize the Company’s cash, cash equivalents, and investments’ adjusted cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category recorded as cash and cash equivalents, and short-term investments as of September 26, 2020 and March 28, 2020 (in thousands):
September 26, 2020 Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Cash & Cash Equivalents Short-term investments
(due in 1 year or less)
Cash $ 188,894  $ —  $ —  $ 188,894  $ 188,894  $ — 
Level 1:
Mutual Funds 13,339  762  (126) 13,975  —  13,975 
Money Market Funds 25,007  —  —  25,007  25,007 
Total cash, cash equivalents
and investments measured at fair value
$ 227,240  $ 762  $ (126) $ 227,876  $ 213,901  $ 13,975 
March 28, 2020 Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Cash & Cash Equivalents Short-term investments (due in 1 year or less)
Cash $ 213,879  $ —  $ —  $ 213,879  $ 213,879  $ — 
Level 1:
Mutual Funds 12,938  31  (1,128) 11,841  —  11,841 
Total cash, cash equivalents
and investments measured at fair value
$ 226,817  $ 31  $ (1,128) $ 225,720  $ 213,879  $ 11,841 

As of September 26, 2020, and March 28, 2020, all of the Company's investments are classified as trading securities and are reported at fair value, with unrealized gains and losses included in current period earnings. For more information regarding the Company's deferred compensation plan, see Note 4, Deferred Compensation.

The Company did not incur any material realized or unrealized gains or losses in the three months ended September 26, 2020, and September 28, 2019. The Company recognized an unrealized gain of $1.8 million during the six months ended September 26, 2020. The Company did not incur any material realized or unrealized gains or losses in the six months ended September 28, 2019.

There were no transfers between fair value measurement levels during the three and six months ended September 26, 2020, and September 28, 2019.

All financial assets and liabilities are recognized or disclosed at fair value in the financial statements. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1
The Company's Level 1 financial assets consist of Mutual Funds and Money Market Funds. The fair value of Level 1 financial instruments is measured based on the quoted market price of identical securities.

Level 2
The Company's Level 2 financial assets and liabilities consist of derivative foreign currency contracts, an interest rate swap, a term loan facility, and 5.50% Senior Notes. The fair value of the Level 2 derivative foreign currency contracts and interest rate swap are determined using pricing models that use observable market inputs. For more information regarding the Company's derivative assets and liabilities, see Note 13, Derivatives. The fair value of the Level 2 5.50% Senior Notes and term loan facility are determined based on inputs that were observable in the market, including the trading price of the notes when available. For more information regarding the Company's 5.50% Senior Notes and term loan facility, see Note 8, Debt.

22

Level 3
The Company's revolving credit facility falls under the Level 3 hierarchy. The fair value of the Level 3 revolving credit facility is determined based on inputs that were unobservable in the market. For more information regarding the Company's debt, refer to Note 8, Debt.

4.  DEFERRED COMPENSATION

As of September 26, 2020, the Company held investments in mutual funds with a fair value totaling $14.0 million, all of which related to debt and equity securities that are held in rabbi trusts under non-qualified deferred compensation plans. The total related deferred compensation liability was $13.9 million at September 26, 2020. As of March 28, 2020, the Company held investments in mutual funds with a fair value totaling $11.8 million, all of which related to debt and equity securities that are held in a rabbi trust under non-qualified deferred compensation plans. The total related deferred compensation liability at March 28, 2020 was $11.7 million.

The securities are classified as trading securities and are recorded on the condensed consolidated balance sheets under "short-term investments". The liability is recorded on the condensed consolidated balance sheets under "other long-term liabilities" and "accrued liabilities".

5. DETAILS OF CERTAIN BALANCE SHEET ACCOUNTS

Accounts receivable, net:
(in thousands) September 26, 2020 March 28, 2020
Accounts receivable $ 326,062  $ 350,642 
Provisions for promotions, rebates, and other (84,823) (101,666)
Provisions for doubtful accounts and sales allowances (1,760) (2,141)
Accounts receivable, net $ 239,479  $ 246,835 

The Company maintains a provision for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The Company regularly performs credit evaluations of its customers’ financial conditions and considers factors such as historical experience, credit quality, age of the accounts receivable balances, geographic or country-specific risks, and economic conditions that may affect a customer’s ability to pay, including any reasonable and supportable forecasts of the future. 

For the three months ended September 26, 2020, our assessment considered business and market disruptions caused by COVID-19 and estimates of credit and collectability trends. The continued volatility in market conditions and evolving shifts in credit trends are difficult to predict, causing variability and volatility that may impact our allowance for credit losses in future periods.

As a result of the Polycom Acquisition (the "Acquisition"), the Company assumed a financing agreement with an unrelated third-party financing company (the "Financing Agreement") whereby the Company offers distributors and resellers direct or indirect financing on their purchases of Polycom's products and services. In return, the Company agrees to pay the financing company a fee based on a pre-defined percentage of the transaction amount financed. In certain instances, these financing arrangements result in a transfer of the Company's receivables, without recourse, to the financing company. If the transaction meets the applicable criteria under Topic 860 and is accounted for as a sale of financial assets, the related accounts receivable is excluded from the balance sheet upon receipt of the third-party financing company's payment remittance. In certain legal jurisdictions, the arrangements that involve maintenance services or products bundled with maintenance at one price do not qualify as a sale of financial assets in accordance with the authoritative guidance. Accordingly, accounts receivable related to these arrangements are accounted for as a secured borrowing in accordance with Topic 860, and the Company records a liability for any cash received, while maintaining the associated accounts receivable balance until the distributor or reseller remits payment to the third-party financing company.
23


During the quarter ended September 26, 2020, total transactions entered pursuant to the terms of the Financing Agreement were approximately $23.6 million, of which $23.6 million was related to the transfer of the financial asset. During the quarter ended September 28, 2019, total transactions entered pursuant to the terms of the Financing Agreement were approximately $44.9 million, of which $27.9 million was related to the transfer of the financial assets. The financing of these receivables accelerated the collection of cash and reduced the Company's credit exposure. Included in "Accounts receivables, net" in the Company's condensed consolidated balance sheets as of September 26, 2020 and March 28, 2020 was approximately $13.0 million and $22.5 million, respectively due from the financing company, of which $13.0 million and $16.5 million, respectively was related to accounts receivable transferred. Total fees incurred pursuant to the Financing Agreement were immaterial for the quarters ended September 26, 2020 and September 28, 2019. These fees are recorded as a reduction to revenue on the Company's condensed consolidated statements of operations.

Inventory, net:
(in thousands) September 26, 2020 March 28, 2020
Raw materials $ 75,440  $ 97,371 
Work in process 4,790  459 
Finished goods 103,406  66,697 
Inventory, net $ 183,636  $ 164,527 

Accrued Liabilities:
(in thousands) September 26, 2020 March 28, 2020
Short term deferred revenue $ 144,383  $ 144,040 
Employee compensation and benefits 61,956  48,153 
Operating lease liabilities, current 21,032  22,517 
Warranty obligation 16,006  12,772 
Provision for returns 14,211  20,146 
Accrued interest 14,099  14,617 
Marketing incentives liabilities 13,430  9,708 
Derivative liabilities 12,541  12,840 
Income tax payable 10,839  20,725 
VAT/Sales tax payable 10,223  9,673 
Accrued other 54,738  58,475 
Accrued liabilities $ 373,458  $ 373,666 

The Company's warranty obligation is included as a component of accrued liabilities on the condensed consolidated balance sheets. Changes in the warranty obligation during the six months ended September 26, 2020 and September 28, 2019 were as follows:
Six Months Ended
(in thousands) September 26, 2020 September 28, 2019
Warranty obligation at beginning of period $ 15,261  $ 17,984 
Warranty provision related to products shipped 13,488  9,573 
Deductions for warranty claims processed (7,981) (9,841)
Adjustments related to preexisting warranties (2,365) (1,916)
Warranty obligation at end of period(1)
$ 18,403  $ 15,800 
(1) Includes both short-term and long-term portion of warranty obligation; the prior table shows only the short-term portion included in accrued liabilities on the Company's condensed consolidated balance sheet. The long-term portion is included in other long-term liabilities.

24

6.    GOODWILL AND PURCHASED INTANGIBLE ASSETS

Goodwill

The changes in the carrying amount of goodwill allocated to the Company's reporting segments for the periods ended September 26, 2020 and March 28, 2020 are as follows:
(in thousands) Poly Reportable Segment Products Reportable Segment Services Reportable Segment Total Consolidated
Balance as of March 30, 2019 $ 1,278,380  $ —  $ —  $ 1,278,380 
Adjustments(1)
1,517  1,517 
Impairment prior to re-segmentation (323,088) —  —  (323,088)
Allocation due to re-segmentation (956,809) 789,561  167,248  — 
Impairment after re-segmentation —  (160,593) (160,593)
Balance as of March 28, 2020 $ —  $ 628,968  $ 167,248  $ 796,216 
Balance as of September 26, 2020 $ —  $ 628,968  $ 167,248  $ 796,216 
(1) Represents measurement period adjustments.

During the fourth quarter of Fiscal Year 2020, the Company experienced a sustained decrease in its stock price and determined that it was more likely than not that the carrying value of the Company's reporting units exceeded their fair value. Additionally, during the fourth quarter of Fiscal Year 2020, the Company made key changes to its executive management, which ultimately resulted in a change to the composition of its reportable segments and consequently a change from one to four reporting units – Headsets, Voice, Video, and Services. These changes resulted in an impairment charge of $483.7 million in the fourth quarter of Fiscal Year 2020.

Other Intangible Assets

As of September 26, 2020, and March 28, 2020, the carrying value of other intangibles, is as follows:
As of September 26, 2020 March 28, 2020
(in thousands) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful Life
Amortizing Assets
Existing technology $ 427,123  $ (244,263) $ 182,860  $ 427,123  $ (208,848) $ 218,275  2.8 years
Customer relationships 240,024  (106,474) 133,550  240,024  (84,506) 155,518  3.6 years
Trade name/Trademarks 115,600  (28,900) 86,700  115,600  (22,478) 93,122  6.8 years
Total intangible assets $ 782,747  $ (379,637) $ 403,110  $ 782,747  $ (315,832) $ 466,915  3.9 years

During the three and six months ended September 26, 2020, the Company recognized $31.4 million and $63.8 million, respectively, in amortization expense. During the three and six months ended September 28, 2019 the Company recognized $46.0 million and $91.3 million, respectively, in amortization expense.

25

As of September 26, 2020, expected amortization expense for other intangible assets for each of the next five years and thereafter is as follows:
in thousands Amount
2021 (remaining six months) $ 61,088 
2022 113,858 
2023 111,232 
2024 65,936 
2025 21,688 
Thereafter 29,308 
$ 403,110 

7. COMMITMENTS AND CONTINGENCIES

Future Minimum Rental Payments

Future minimum lease payments under non-cancelable operating leases as of September 26, 2020 were as follows:
(in thousands)
Operating Leases(1)
2021 (remaining six months) $ 12,014 
2022 21,022 
2023 8,559 
2024 6,845 
2025 5,572 
Thereafter 16,215 
Total lease payments $ 70,227 
Less: Imputed interest(2)
(8,036)
Present value of lease liabilities $ 62,191 
(1) The weighted average remaining lease term was 4.4 years as of September 26, 2020.
(2) The weighted average discount rate was 4.8% as of September 26, 2020.

Unconditional Purchase Obligations

The Company purchases materials and services from a variety of suppliers and manufacturers. During the normal course of business and to manage manufacturing operations and general and administrative activities, the Company may enter into firm, non-cancelable, and unconditional purchase obligations for which amounts are not recorded on the consolidated balance sheets.  As of September 26, 2020, the Company had outstanding off-balance sheet third-party manufacturing, component purchase, and other general and administrative commitments of $420.4 million.

Other Guarantees and Obligations

In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, purchasers of assets or subsidiaries and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company's breach of agreements or representations and warranties made by the Company, services to be provided by the Company, intellectual property infringement claims made by third parties or, with respect to the sale of assets of a subsidiary, matters related to the Company's conduct of business and tax matters prior to the sale. From time to time, the Company indemnifies customers against combinations of loss, expense, or liability arising from various triggering events relating to the sale and use of its products and services.  

26

In addition, the Company also provides indemnification to customers against claims related to undiscovered liabilities, additional product liability, or environmental obligations. The Company has also entered into indemnification agreements with its directors, officers and certain other personnel that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers of the Company or certain of its affiliated entities. The Company maintains director and officer liability insurance, which may cover certain liabilities arising from its obligation to indemnify its directors, officers and certain other personnel in certain circumstances. It is not possible to determine the aggregate maximum potential loss under these agreements due to the limited history of prior claims and the unique facts and circumstances involved in each particular claim. Such indemnification obligations might not be subject to maximum loss clauses. Historically, the Company has not incurred material costs as a result of obligations under these agreements and it has not accrued any liabilities related to such indemnification obligations in the condensed consolidated financial statements.

Claims and Litigation

On October 12, 2012, GN Netcom, Inc. (“GN”) filed a complaint against the Company in the United States District Court for the District of Delaware (“Court”), alleging violations of Sections 1 and 2 of the Sherman Act, Section 3 of the Clayton Act, and tortious interference with business relations in connection with the Company’s distribution of corded and wireless headsets. On July 13, 2020 the parties resolved the dispute and the matter was dismissed.

On January 23, 2018, FullView, Inc. filed a complaint in the United States District Court of the Northern District of California against Polycom, Inc. alleging infringement of two patents and thereafter filed a similar complaint in connection with the same patents in Canada.  Polycom thereafter filed an inter partes reexamination ("IPR") of one of the patents, which was then appealed to Federal Circuit Court and denied. Litigation in both matters in the United States and Canada, respectively, were stayed pending the results of that appeal. Polycom also filed an IPR of the second patent and the PTAB denied institution of the IPR petition.  FullView had also initiated arbitration proceedings under a terminated license agreement with Polycom alleging that Polycom had failed to pay certain royalties due under that agreement.  The arbitration panel awarded an immaterial amount to FullView.  FullView filed a First and Second Amended Complaint and Polycom filed a motion to dismiss. The Court granted Polycom's partial motion to dismiss without prejudice and invalidated one of the patents in suit. Litigation on the remaining patent is ongoing.

On June 21, 2018, directPacket Research Inc. filed a complaint alleging patent infringement by Polycom in the United States District Court for the Eastern District of Virginia, Norfolk Division.  The Court granted Polycom’s Motion to Transfer Venue to the Northern District of California.  Polycom filed petitions for Inter Partes Review of the asserted patents which were granted by the U.S. Patent Trial and Appeal Board.  The District Court matter is stayed pending resolution of the IPRs. Oral argument was heard on the IPRs on October 20, 2020 with ruling expected on or around January 2021.

On November 15, 2019, Felice Bassuk, individually and on behalf of others similarly situated, filed a complaint against Plantronics, its CEO Joseph Burton, its CFO Charles Boynton and its former CFO Pamela Strayer alleging various securities law violations. Plaintiffs filed the amended complaint on June 5, 2020 and the Company’s Motion to Dismiss the Amended Complaint was filed on August 7, 2020.  Plaintiffs filed their Opposition on October 2, 2020 with Plantronics’ reply due on November 16, 2020. The hearing on the Motion to Dismiss currently is scheduled to occur on January 13, 2021.

On December 17, 2019, Cisco Systems, Inc. filed a First Amended Complaint for Trade Secret Misappropriation against Plantronics, Inc. and certain individuals which amends a previously filed complaint against certain other individuals.  The Company disputes the allegations.  The Company filed a Motion to Dismiss.  The Court granted the Motion to Dismiss with leave to amend as to Defendants He, Chung and Williams, granted the Motion to Compel Arbitration for Defendant Williams and granted in part and denied in part the Motion to Dismiss by Defendants Puorro and Poly.  Cisco filed an Amended Complaint and the Defendants have moved to dismiss or strike portions of the Amended Complaint. The Court granted in part and denied in part the Motion to Dismiss. The matter is ongoing.

On July 22, 2020, Koss Corporation sued Plantronics and Polycom in the Western District of Texas, Waco division alleging patent infringement with respect to four Koss patents.  The Company answered the Complaint on October 1, 2020 disputing the claims. The matter is ongoing.  

27

In addition to the specific matters discussed above, the Company is involved in various legal proceedings and investigations arising in the normal course of conducting business. Where applicable, in relation to the on-going matters described above, the Company has accrued an amount that reflects the aggregate liability deemed probable and estimable, but this amount is not material to the Company's financial condition, results of operations, or cash flows. The Company is not able to estimate an amount or range of any reasonably possible loss, including in excess of any amount accrued, because of the preliminary nature of many of these proceedings, the difficulty in ascertaining the applicable facts relating to many of these proceedings, the variable treatment of claims made in many of these proceedings, and the difficulty of predicting the settlement value of many of these proceedings. However, based upon the Company's historical experience, the resolution of these proceedings is not expected to have a material effect on the Company's financial condition, results of operations or cash flows. The Company may incur substantial legal fees, which are expensed as incurred, in defending against these legal proceedings.

8. DEBT

The estimated fair value and carrying value of the Company's outstanding debt as of September 26, 2020 and March 28, 2020 were as follows:
September 26, 2020 March 28, 2020
(in thousands) Fair Value Carrying Value Fair Value Carrying Value
5.50% Senior Notes $ 441,455  $ 488,830  $ 359,140  $ 495,409 
Term loan facility $ 1,053,992  $ 1,098,726  $ 852,942  $ 1,126,285 

As of September 26, 2020, and March 28, 2020, the net unamortized discount, premium and debt issuance costs on the Company's outstanding debt were $21.9 million and $25.1 million, respectively.

5.50% Senior Notes

In May 2015, the Company issued $500.0 million aggregate principal amount of 5.50% senior notes (the “5.50% Senior Notes”). The 5.50% Senior Notes mature on May 31, 2023, and bear interest at a rate of 5.50% per annum, payable semi-annually on May 15 and November 15, commencing on November 15, 2015. The Company received net proceeds of $488.4 million from the issuance of the 5.50% Senior Notes, net of issuance costs of $11.6 million which are being amortized to interest expense over the term of the 5.50% Senior Notes using the effective interest method. A portion of the proceeds was used to repay all then-outstanding amounts under the Company's revolving line of credit agreement with Wells Fargo Bank and the remaining proceeds were used primarily for share repurchases.

The fair value of the 5.50% Senior Notes was determined based on inputs that were observable in the market, including the trading price of the 5.50% Senior Notes when available (Level 2).

The Company may redeem all or a part of the 5.50% Senior Notes, upon not less than 30 or more than a 60-day notice; however, the applicable redemption price is the principal plus a premium which declines over time as specified in the applicable indenture, together with accrued and unpaid interest.

In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase the 5.50% Senior Notes, at a price equal to 101% of their principal amount, plus accrued and unpaid interest to the date of repurchase. The 5.50% Senior Notes contain restrictive covenants that, among other things, limit the Company's ability to create certain liens and enter into sale and lease-back transactions; create, assume, incur, or guarantee additional indebtedness of its subsidiaries without such subsidiary guaranteeing the 5.50% Senior Notes on an unsecured unsubordinated basis; and consolidate or merge with, or convey, transfer or lease all or substantially all of the assets of the Company and its subsidiaries, to another person. During the three months ended September 26, 2020, the Company repurchased $7.4 million aggregate principal amount of the 5.50% Senior Notes. The Company recorded an immaterial gain on the repurchase, which is included in interest expense of the Company's condensed consolidated statements of operations.

Credit Facility Agreement

In connection with the Polycom Acquisition completed on July 2, 2018, the Company entered into a Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto (the “Credit Agreement”). The Credit Agreement replaced the Company’s prior revolving credit facility in its entirety. The Credit Agreement provides for (i) a revolving credit facility with an initial maximum aggregate amount of availability of $100 million that matures in July 2023 and (ii) a $1.275 billion term loan facility priced at LIBOR plus 250bps due in quarterly principal installments commencing on the
28

last business day of March, June, September and December beginning with the first full fiscal quarter ending after the Closing Date for the aggregate principal amount funded on the Closing Date multiplied by 0.25% (subject to prepayments outlined in the Credit Agreement) and all remaining outstanding principal due at maturity in July 2025. The Company borrowed the full amount available under the term loan facility of $1.245 billion, net of approximately $30 million of discounts and issuance costs which are being amortized to interest expense over the term of the agreement using the straight-line method which approximates the effective interest method for this debt. The proceeds from the initial borrowing under the Credit Agreement were used to finance the Acquisition, to refinance certain debt of Polycom, and to pay related fees, commissions and transaction costs. The Company has additional borrowing capacity under the Credit Agreement through the revolving credit facility which could be used to provide ongoing working capital and capital for other general corporate purposes of the Company and its subsidiaries. The Company’s obligations under the Credit Agreement are currently guaranteed by Polycom and will from time to time be guaranteed by, subject to certain exceptions, any domestic subsidiaries that may become material in the future. Subject to certain exceptions, the Credit Agreement is secured by first-priority perfected liens and security interests in substantially all of the personal property of the Company and each subsidiary guarantor and will from time to time also be secured by certain material real property that the Company or any subsidiary guarantor may acquire. Borrowings under the Credit Agreement bear interest due on a quarterly basis at a variable rate equal to (i) LIBOR plus a specified margin, or (ii) the base rate (which is the highest of (a) the prime rate publicly announced from time to time by Wells Fargo Bank, National Association, (b) the federal funds rate plus 0.50% or (c) the sum of 1% plus one-month LIBOR) plus a specified margin. The Company must also pay (i) an unused commitment fee ranging from 0.200% to 0.300% per annum of the average daily unused portion of the aggregate revolving credit commitments under the Credit Agreement, and (ii) a per annum fee equal to (a) for each performance standby letter of credit outstanding under the Credit Agreement with respect to non-financial contractual obligations, 50% of the applicable margin over LIBOR under the revolving credit facility in effect from time to time multiplied by the daily amount available to be drawn under such letter of credit, and (b) for each other letter of credit outstanding under the Credit Agreement, the applicable margin over LIBOR under the revolving credit facility in effect from time to time multiplied by the daily amount available to be drawn under such letter of credit.

On February 20, 2020, the Company entered into an Amendment No. 2 to Credit Agreement (the “Amendment”) by and among the Company, the financial institutions party thereto as lenders and Wells Fargo Bank, National Association, as administrative agent (in such capacity, the “Agent”). The Amendment amended the Credit Agreement, as previously amended to (i) increase the maximum Secured Net Leverage Ratio (as defined in the Credit Agreement) permitted under the Credit Agreement to 3.75 to 1.00 through December 26, 2020 and 3.00 to 1.00 thereafter and (ii) decrease the minimum Interest Coverage Ratio (as defined in the Credit Agreement) required under the Credit Agreement to 2.25 to 1.00 through December 26, 2020 and 2.75 to 1.00 thereafter.

Additionally, the Amendment modified the calculation of the Secured Net Leverage Ratio and the Interest Coverage Ratio solely for purposes of compliance with Sections 7.11(a) and 7.11(b) of the Credit Agreement to (i) calculate the Secured Net Leverage Ratio net of the aggregate amount of unrestricted cash and Cash Equivalents (as defined in the Credit Agreement) on the balance sheet of the Company and its Restricted Subsidiaries (as defined in the Credit Agreement) as of the date of calculation up to an amount equal to $150,000,000 and (ii) solely for purposes of any fiscal quarter ending from December 29, 2019 through December 26, 2020, increase the cap on Expected Cost Savings (as defined in the Credit Agreement) in determining Consolidated EBITDA (as defined in the Credit Agreement) to the greater of (A) 20% of Consolidated EBITDA for such Measurement Period (as defined in the Credit Agreement) (calculated before giving effect to any such Expected Cost Savings to be added back pursuant to clause (a)(ix) of the definition of Consolidated EBITDA) and (B)(x) for the period from December 29, 2019 through March 28, 2020, $121,000,000, (y) for the period from March 29, 2020 through June 27, 2020, $107,000,000 and (z) for the period from June 28, 2020 through December 26, 2020, $88,000,000.
The financial covenants under the Credit Agreement described above are for the benefit of the revolving credit lenders only and do not apply to any other debt of the Company. The Credit Agreement also contains various other restrictions and covenants, some of which have become more stringent over time, including restrictions on our, and certain of our subsidiaries, ability to consolidate or merge, create liens, incur additional indebtedness, dispose of assets, consummate acquisitions, make investments and pay dividends and other distributions. The Company has the unilateral ability to terminate the revolving line of credit such that the financial covenants described above are no longer applicable. The Credit Agreement also contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable; provided, however, that the occurrence of an event of default as a result of a breach of a financial covenant under the Credit Agreement does not constitute a default or event of default with respect to any term facility under the Credit Agreement unless and until the required revolving lenders shall have terminated their revolving commitments and declared all amounts outstanding under the revolving credit facility to be due and payable. In addition, if the Company, any subsidiary guarantor or, with certain exceptions, any other subsidiary becomes the subject of voluntary or involuntary proceedings under any bankruptcy, insolvency or similar law, then any outstanding obligations under the Credit Agreement will automatically become immediately due and payable. Loans
29

outstanding under the Credit Agreement will bear interest at a rate of 2.00% per annum in excess of the otherwise applicable rate (i) while a payment or bankruptcy event of default exists or (ii) upon the lenders’ request, during the continuance of any other event of default. As of September 26, 2020, the Company was in compliance with the financial covenants.

The Company may prepay the loans and terminate the commitments under the Credit Facility Agreement at any time without penalty. Additionally, the Company is subject to mandatory debt repayments five business days after the filing of its financial statements for any annual period in which the Company generates excess cash as defined by the Credit Agreement. In accordance with the terms of the Credit Agreement, the Company did not generate excess cash during Fiscal Year 2020 and therefore is not required to make any debt repayments in Fiscal Year 2021. During the three months ended September 26, 2020, the Company repurchased $30.0 million aggregate principal amount of the term loan facility. The Company recorded an immaterial gain on the repurchase, which is included in interest expense on the Company's condensed consolidated statements of operations. As of September 26, 2020, the Company has five outstanding letters of credit on the revolving credit facility for a total of $1.4 million. The fair value of the term loan facility was determined based on inputs that were observable in the market (Level 2).

9. RESTRUCTURING AND OTHER RELATED CHARGES

Summary of Restructuring Plans

Fiscal Year 2021 restructuring plan

During the six months ended September 26, 2020, the Company committed to additional actions to reduce expenses and right size its overall cost structure to better align with projected revenue levels. The costs incurred to date under this plan include severance benefits related to headcount reductions in the Company's global workforce and facility related charges due to closure or consolidation of leased offices.

Fiscal Year 2020 restructuring plans

During the Fiscal Year 2020, the Company committed to additional actions to rationalize post-Acquisition operations and costs to align the Company's cost structure to current revenue expectations. The costs incurred to date under these plans include severance benefits related to headcount reductions in the Company's global workforce, facility related charges due to consolidation of the Company's leased offices, asset impairments associated with consumer product portfolio optimization efforts, and other costs associated with legal entity rationalization.

Fiscal Year 2019 restructuring plans

During the Fiscal Year 2019, the Company initiated post-Acquisition restructuring plans to realign the Company's cost structure, including streamlining the global workforce, consolidation of certain distribution centers in North America, and reduction of redundant legal entities, in order to take advantage of operational efficiencies following the Acquisition. The costs incurred to date under these plans have primarily comprised of severance benefits from reduction in force actions, facilities related actions initiated by management, and legal entity rationalization.

The following table summarizes the restructuring and other related charges recognized in the Company's condensed consolidated statements of operations:
Three Months Ended Six Months Ended
(in thousands) September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Severance $ 881  $ 77  $ 23,192  $ 13,772 
Facility (156) —  1,642  — 
Other (1)
867  1,037  2,308  6,867 
Non-cash charges (2)
4,578  4,733  8,358  4,733 
Total restructuring and other related charges $ 6,170  $ 5,847  $ 35,500  $ 25,372 
(1) Other costs primarily represent associated legal and advisory services.
(2) Non-cash charges primarily represent asset impairment

30

The Company's restructuring liabilities as of September 26, 2020 is as follows (amounts in thousands):
As of March 28, 2020  Accruals  Cash Payments As of September 26, 2020
FY 2021 Plans
 Severance $ —  $ 23,808  $ (15,922) $ 7,886 
 Facility —  69  (59) 10 
 Other —  2,307  (1,651) 656 
Total FY2021 Plans $ —  $ 26,184  $ (17,632) $ 8,552 
FY 2020 Plans
 Severance $ 7,475  $ (859) $ (4,499) $ 2,117 
 Facility 2,501  1,573  (852) 3,222 
 Other 1,621  —  (1,621) — 
Total FY2020 Plans $ 11,597  $ 714  $ (6,972) $ 5,339 
FY 2019 Plans
 Severance $ 147  $ 243  $ (325) $ 65 
 Facility —  —  —  — 
 Other 117  —  (117) — 
Total FY2019 Plans $ 264  $ 243  $ (442) $ 65 
 Severance $ 7,622  $ 23,192  $ (20,746) $ 10,068 
 Facility 2,501  1,642  (911) 3,232 
 Other 1,738  2,307  (3,389) 656 
Grand Total $ 11,861  $ 27,141  $ (25,046) $ 13,956 


10. STOCK-BASED COMPENSATION

Stock-based Compensation

The Company recognizes the grant-date fair value of stock-based compensation as compensation expense using the straight-line attribution approach over the service period for which the stock-based compensation is expected to vest. The following table summarizes the amount of stock-based compensation included in the condensed consolidated statements of operations:
Three Months Ended Six Months Ended
(in thousands) September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Cost of revenues $ 742  $ 997  $ 1,575  $ 1,975 
Research, development, and engineering 4,068  4,213  7,299  7,932 
Selling, general, and administrative 5,453  9,483  10,749  17,690 
Stock-based compensation included in operating expenses 9,521  13,696  18,048  25,622 
Total stock-based compensation 10,263  14,693  19,623  27,597 
Income tax benefit (3,197) (3,147) (8,170) (3,143)
Total stock-based compensation, net of tax $ 7,066  $ 11,546  $ 11,453  $ 24,454 

31

11. COMMON STOCK REPURCHASES

From time to time, the Company's Board of Directors (the "Board") has authorized programs under which the Company may repurchase shares of its common stock, depending on market conditions, in the open market or through privately negotiated transactions. Repurchased shares are held as treasury stock until they are retired or re-issued. On November 28, 2018, the Board approved a 1 million share repurchase program expanding its capacity to repurchase shares to approximately 1.7 million shares. As of September 26, 2020, there remained 1,369,014 shares authorized for repurchase under the repurchase program approved by the Board.

For the periods ended September 26, 2020 and September 28, 2019, the Company did not repurchase any shares of its common stock.

The total value of shares withheld in satisfaction of employee tax obligations on the vesting of equity awards for the three months ended September 26, 2020 and September 28, 2019 were $0.3 million and $0.7 million, respectively. The amounts withheld were equivalent to the employees' minimum statutory tax withholding requirements and are reflected as a financing activity within the Company's condensed consolidated statements of cash flows. These share withholdings have the same effect as share repurchases by the Company as they reduce the number of shares that would have otherwise been issued in connection with the vesting of shares subject to the restricted stock grants.

12. ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of accumulated other comprehensive income ("AOCI"), net of immaterial tax effects, are as follows:
(in thousands) September 26, 2020 March 28, 2020
Accumulated unrealized loss on cash flow hedges (1)
$ (14,265) $ (18,197)
Accumulated foreign currency translation adjustments 4,615  4,615 
Accumulated other comprehensive loss $ (9,650) $ (13,582)
(1) Refer to Note 13, Derivatives, which discloses the nature of the Company's derivative assets and liabilities as of September 26, 2020 and March 28, 2020.

13. DERIVATIVES

Foreign Currency Derivatives

The Company's foreign currency derivatives consist primarily of foreign currency forward exchange contracts and option contracts. The Company does not purchase derivative financial instruments for speculative trading purposes. The derivatives expose the Company to credit risk to the extent the counterparties may be unable to meet the terms of the derivative instrument. The Company's maximum exposure to loss that it would incur due to credit risk if parties to derivative contracts failed completely to perform according to the terms of the contracts was equal to the carrying value of the Company's derivative assets as of September 26, 2020 and March 28, 2020. The Company seeks to mitigate such risk by limiting its counterparties to large financial institutions. In addition, the Company monitors the potential risk of loss with any one counterparty resulting from this type of credit risk on an ongoing basis.

The Company enters into master netting arrangements with counterparties when possible to mitigate credit risk in derivative transactions. A master netting arrangement may allow each counterparty to net settle amounts owed between the Company and the counterparty as a result of multiple, separate derivative transactions. As of September 26, 2020, the Company had International Swaps and Derivatives Association ("ISDA") agreements with four applicable banks and financial institutions which contained netting provisions. The Company has elected to present the fair value of derivative assets and liabilities within the Company's condensed consolidated balance sheet on a gross basis even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. For each counterparty, if netted, the Company would offset the asset and liability balances of all derivatives at the end of the reporting period. Derivatives not subject to master netting agreements are not eligible for net presentation. As of September 26, 2020, and March 28, 2020, no cash collateral had been received or pledged related to these derivative instruments.

32

The gross fair value of the Company's outstanding derivative contracts at the end of each period was as follows:
(in thousands) September 26, 2020 March 28, 2020
Derivative Assets(1)
Non-designated hedges $ 698  $ 266 
Cash flow hedges 654  3,283 
Total derivative assets $ 1,352  $ 3,549 
Derivative Liabilities(2)
Non-designated hedges $ 16  $ 668 
Cash flow hedges 2,060  811 
Interest rate swap 15,920  21,411 
Accrued interest 965  631 
Total derivative liabilities $ 18,961  $ 23,521 
(1) Short-term derivative assets are recorded in "other current assets" and long-term derivative assets are recorded in "deferred tax and other assets". As of September 26, 2020, the portion of derivative assets classified as long-term was immaterial.

(2) Short-term derivative liabilities are recorded in "accrued liabilities" and long-term derivative liabilities are recorded in "other long-term liabilities". As of September 26, 2020, the portion of derivative liabilities classified as long-term was $5.5 million.

Non-Designated Hedges

As of September 26, 2020, the Company had foreign currency forward contracts denominated in Euros ("EUR") and British Pound Sterling ("GBP"). The Company does not elect to obtain hedge accounting for these forward contracts. These forward contracts hedge against a portion of the Company’s foreign currency-denominated cash balances, receivables, and payables. The following table summarizes the notional value of the Company’s outstanding foreign exchange currency contracts and approximate U.S. Dollar ("USD") equivalent at September 26, 2020:
 (in thousands) Local Currency USD Equivalent Position Maturity
EUR 50,800  $ 59,059  Sell EUR 1 month
GBP £ 3,600  $ 4,574  Sell GBP 1 month

Effect of Non-Designated Derivative Contracts on the Condensed Consolidated Statements of Operations

The effect of non-designated derivative contracts recognized in other non-operating income and (expense), net in the condensed consolidated statements of operations was as follows:
Three Months Ended Six Months Ended
(in thousands) September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Gain (loss) on foreign exchange contracts $ (1,815) $ 3,610  $ (2,733) $ 3,321 

Cash Flow Hedges

Costless Collars

The Company hedges a portion of the forecasted EUR and GBP denominated revenues with costless collars. On a monthly basis, the Company enters into option contracts with a six to eleven-month term. Collar contracts are scheduled to mature at the beginning of each fiscal quarter, at which time the instruments convert to forward contracts. The Company also enters into cash flow forwards with a three-month term. Once the hedged revenues are recognized, the forward contracts become non-designated hedges to protect the resulting foreign monetary asset position for the Company. 

33

The notional value of the Company's outstanding EUR and GBP option and forward contracts at the end of each period was as follows:
(in millions) September 26, 2020 March 28, 2020
EUR GBP EUR GBP
Option contracts €60.7 £12.3 €67.0 £18.4
Forward contracts €51.8 £11.0 €50.2 £18.5

The Company will reclassify all amounts accumulated in other comprehensive income into earnings within the next twelve months.

Interest Rate Swap

On July 30, 2018, the Company entered into a 4-year amortizing interest rate swap agreement with Bank of America, N.A. The swap has an initial notional amount of $831 million and matures on July 31, 2022. The swap involves the receipt of floating-rate interest payments for fixed interest rate payments at a rate of 2.78% over the life of the agreement. The Company has designated this interest rate swap as a cash flow hedge. The purpose of this swap is to hedge against changes in cash flows (interest payments) attributable to fluctuations in the Company's variable rate debt. The derivative is valued based on prevailing LIBOR rate curves on the date of measurement. The Company also evaluates counterparty credit risk when it calculates the fair value of the swap. The effective portion of changes in the fair value of the derivative is recorded to other comprehensive income (loss) on the accompanying balance sheets and reclassified into interest expense over the life of the underlying debt as interest on the Company's floating rate debt is accrued. The Company reviews the effectiveness of this instrument on a quarterly basis, recognize current period hedge ineffectiveness immediately in earnings and will discontinue hedge accounting if the Company no longer considers hedging to be highly effective. This hedge was fully effective at inception on July 30, 2018 and as of the six months ended September 26, 2020. During the six months ended September 26, 2020, the Company reclassified into interest expense $7.3 million and had a $15.9 million unrealized loss on its interest rate swap derivative designated as a cash flow hedge.

Effect of Designated Derivative Contracts on AOCI and Condensed Consolidated Statements of Operations

The following table presents the pre-tax effects of derivative instruments designated as cash flow hedges on accumulated other comprehensive income and the condensed consolidated statements of operations for the three and six months ended September 26, 2020 and September 28, 2019:
Three Months Ended Six Months Ended
(in thousands) September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Gain (loss) included in AOCI as of beginning of period $ (18,921) $ (14,995) $ (20,156) $ (7,480)
Amount of gain (loss) recognized in other comprehensive income (“OCI”) (effective portion) (3,006) 2,369  (4,585) (4,335)
Amount of (gain) loss reclassified from OCI into net revenues (effective portion) 1,652  (1,568) 743  (2,927)
Amount of (gain) loss reclassified from OCI into cost of revenues (effective portion) —  (62) —  (166)
Amount of (gain) loss reclassified from OCI into interest expense (effective portion) 3,528  945  7,251  1,597 
Total amount of (gain) loss reclassified from AOCI to income (loss) (effective portion) 5,180  (685) 7,994  (1,496)
Gain (loss) included in AOCI as of end of period $ (16,747) $ (13,311) $ (16,747) $ (13,311)

As a result of adopting ASU 2017-12, beginning in the first quarter of fiscal year 2020, the excluded portion of such amounts is included in the same line item in which the underlying transactions affect earnings and the ineffective portion of the realized and unrealized gains or losses on derivatives is included as a component of accumulated other comprehensive income. During the three and six months ended September 26, 2020 and September 28, 2019, the Company did not have an ineffective portion of its cash flow hedges.

34

14. INCOME TAXES

The Company and its subsidiaries are subject to taxation in the U.S. and in various foreign and state jurisdictions. The Company's tax benefit is determined using an estimate of its annual effective tax rate and adjusted for discrete items that are taken into account in the relevant period. The effective tax rates for the three months ended September 26, 2020 and September 28, 2019 were (29.0)% and 13.7%, respectively. The effective tax rates for the six months ended September 26, 2020 and September 28, 2019 were 0.2% and 14.2%. respectively.

As of September 26, 2020, the Company had approximately $86.3 million in non-US net deferred tax assets ("DTAs") after valuation allowance, and continued to maintain a 100% valuation allowance against its U.S. federal and state deferred tax assets. A significant portion of the Company's DTAs relate to internal intangible property restructuring between wholly-owned subsidiaries. At this time, based on evidence currently available, the Company considers it more likely than not that it will have sufficient taxable income in the future that will allow the Company to realize the DTAs; however, failure to generate sufficient taxable income could result in some or all DTAs not being utilized in the future. If the Company is unable to generate sufficient future taxable income, a substantial valuation allowance to reduce the Company's DTAs may be required.

The Company is subject to the examination of its income tax returns by the Internal Revenue Service and other tax authorities. Significant judgment is required in evaluating our uncertain tax positions and determining the Company's provision for income taxes. As of September 26, 2020, the Company had a total gross unrecognized tax benefits of $28.8 million compared with $37.2 million as of September 28, 2019. The reduction in gross unrecognized tax benefits is primarily attributed to examination closure and settlement by the IRS relating to our 2017 Fiscal Year income tax return related to reversal of the United States Tax Court’s holding in Altera Corp. v. Commissioner that upheld the portion of the Treasury regulations issued under IRC Section 482 requiring related-party participants in a cost sharing arrangement to share stock-based compensation costs. If recognized, the gross unrecognized tax benefits would reduce the effective tax rate in the period of recognition.

15. COMPUTATION OF EARNINGS (LOSS) PER COMMON SHARE

Basic earnings (loss) per share is calculated by dividing net income (loss) associated with common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share assumes the issuance of additional shares of common stock by the Company upon exercise of all outstanding stock options and vesting of restricted stock, if the effect is dilutive, in accordance with the treasury stock method or two-class method (whichever is more dilutive).

The following table sets forth the computation of basic loss per common share for the three and six months ended September 26, 2020, and September 28, 2019:
Three Months Ended Six Months Ended
(in thousands, except per share data) September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Basic loss per common share:    
Numerator:
Net loss $ (13,405) $ (25,910) $ (88,420) $ (70,781)
Denominator:
Weighted average common shares, basic 40,970  39,584  40,715  39,411 
Weighted average common shares-diluted 40,970  39,584  40,715  39,411 
Basic loss per common share $ (0.33) $ (0.65) $ (2.17) $ (1.80)
Diluted loss per common share $ (0.33) $ (0.65) $ (2.17) $ (1.80)
Potentially dilutive securities excluded from diluted loss per common share because their effect is anti-dilutive 1,153  1,758  1,337  912 

35

16. REVENUE AND MAJOR CUSTOMERS

The Company designs, manufactures, markets, and sells integrated communications and collaboration solutions that span headsets, open Session Initiation Protocol ("SIP") and native ecosystem desktop phones, conference room phones, video conferencing solutions and peripherals, including cameras, speakers, and microphones, cloud management and analytics software solutions, and services.

Major product categories are Headsets, which includes wired and wireless communication headsets; Voice, Video, and Content Sharing Solutions, which includes open Session Initiation Protocol (“SIP”) and native ecosystem desktop phones, conference room phones, and video conferencing solutions and peripherals, including cameras, speakers, and microphones. All of the Company's solutions are designed to integrate seamlessly with the platform and services of our customers choice in a wide range of Unified Communications & Collaboration ("UC&C"), Unified Communication as a Service ("UCaaS"), and Video as a Service ("VaaS") environments. The Company's cloud management and analytics software enables IT administrators to configure and update firmware, monitor device usage, troubleshoot, and gain a deep understanding of user behavior. In addition, the Company has a broad portfolio of Services including video interoperability, support for our solutions and hardware devices, as well as professional, hosted, and managed services that are grounded in our deep expertise aimed at helping customers achieve their goals for collaboration.

Product revenue is largely comprised of sales of hardware devices, peripherals, and platform software licenses used in communication and collaboration in offices and contact centers, with mobile devices, cordless phones, and computers. Services revenue primarily includes support on hardware devices, professional, hosted and managed services, and solutions to the Company's customers.

The following table disaggregates revenues by major product category for the three and six months ended September 26, 2020 and September 28, 2019:
Three Months Ended Six Months Ended
(in thousands) September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Net revenues from unaffiliated customers:
Headsets1
202,840  206,292  377,590  424,942 
   Voice2
49,069  98,453  99,750  202,300 
   Video2
95,768  90,392  161,795  150,640 
   Services2
63,292  66,572  127,554  131,594 
Total net revenues $ 410,969  $ 461,709  $ 766,689  $ 909,476 
1 As announced on February 4, 2020, the Company entered into a definitive agreement with Nacon S.A. and closed the transaction on March 19, 2020, completing the sale of the Company's Consumer Gaming assets for a net amount that is not material to the Company's condensed consolidated financial statements. The remaining consumer headsets are included in the Company's Enterprise products and all prior periods have been reclassified to conform to current presentation.
2 Categories were introduced with the acquisition of Polycom on July 2, 2018, and amounts are presented net of purchase accounting adjustments.

36

For reporting purposes, revenue is attributed to each geographic region based on the location of the customer. Other than the U.S., no country accounted for 10% or more of the Company's net revenues for the three and six months ended September 26, 2020 and September 28, 2019. The following table presents net revenues by geography:
Three Months Ended Six Months Ended
(in thousands) September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Products
Net revenues from unaffiliated customers:
U.S. $ 159,532  $ 187,935  $ 303,821  $ 386,716 
Europe and Africa 114,875  111,672  192,493  212,778 
Asia Pacific 52,548  68,821  97,979  126,073 
Americas, excluding U.S. 20,722  26,709  44,842  52,315 
Total international net revenues 188,145  207,202  335,314  391,166 
Product net revenues $ 347,677  $ 395,137  $ 639,135  $ 777,882 
Services
Net revenues from unaffiliated customers:
U.S. $ 24,245  $ 25,192  $ 48,237  $ 51,238 
Europe and Africa 15,524  17,301  32,012  33,175 
Asia Pacific 19,021  18,632  37,854  36,228 
Americas, excluding U.S. 4,502  5,447  9,451  10,953 
Total international net revenues 39,047  41,380  79,317  80,356 
Service net revenues $ 63,292  $ 66,572  $ 127,554  $ 131,594 
Total net revenues $ 410,969  $ 461,709  $ 766,689  $ 909,476 

Two customers, ScanSource and Ingram Micro Group, accounted for 25.0% and 18.3%, respectively, of net revenues for the three months ended September 26, 2020. Ingram Micro Group and ScanSource, accounted for 19.7% and 18.3%, respectively, of net revenues for the six months ended September 26, 2020. Two customers, ScanSource and Ingram Micro Group, accounted for 21.7% and 16.8% of net revenues for the three months ended September 28, 2019, respectively. ScanSource and Ingram Micro Group accounted for 19.6% and 16.8%, respectively, of net revenue for the six months ended September 28, 2019.

Two customers, ScanSource and Ingram Micro Group accounted for 24.9% and 23.3%, respectively, of total net accounts receivable at September 26, 2020. Three customers, Ingram Micro Group, ScanSource, and Synnex Group, accounted for 22.2%, 17.3%, and 15.6%, respectively, of total net accounts receivable at March 28, 2020.

Revenue is recognized when obligations under the terms of a contract with the Company's customer are satisfied; generally, this occurs with the transfer of control of its products or services. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. The majority of the Company's business relates to physical product shipments, for which revenue is generally recognized once title and risk of loss of the product are transferred to the customer. The Company believes that transfer of title and risk of loss best represent the moment at which the customer’s ability to direct the use of and obtain substantially all the benefits of an asset have been achieved. The Company has elected to account for shipping and handling as fulfillment cost and recognize the related costs when control over products have transferred to the customer as an expense in Cost of Revenues.

37

The Company's service revenue is recognized either over-time or at a point-in-time depending on the nature of the offering. Revenues associated with non-cancelable maintenance and support contracts comprise approximately 90% of the Company's overall service revenue and are recognized ratably over the contract term, which typically ranges between one and three years. The Company believes this recognition period faithfully depicts the pattern of transfer of control for maintenance and support as the services are a series of distinct services available and delivered daily over the term. For certain products, support is provided free of charge without the purchase of a separate maintenance contract. If the support is determined to rise to the level of a performance obligation, the Company allocates a portion of the transaction price to the implied support obligation and recognizes service revenue over the estimated implied support period which can range between one month to several years, depending on the circumstances. Revenues associated with Professional Services are recognized when the Company has objectively determined that the obligation has been satisfied, which is usually upon customer acceptance.

The Company's contracts with customers often include promises to transfer multiple products and services to a customer. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. The Company allocates the transaction price of a contract, to each identified performance obligation based on stand-alone selling price (“SSP”). The Company determines if variable consideration is associated with one or many, but not all of the performance obligations and allocates accordingly. Judgment is also required to determine the SSP for each distinct performance obligation. The Company derives SSP for its performance obligations through a stratification methodology and considers a few characteristics including consideration related to different service types, customer and geography characteristics. In instances where SSP is not directly observable, such as when the Company does not sell the product or service separately, the Company determines the SSP using information that may include market conditions and other observable inputs.

On occasion, the Company will fulfill only part of a purchase order due to lack of current availability for one or more items requested on an order. Its practice is to ship what is on hand, with the remaining goods shipped once the product is in stock. Shipment generally occurs less than one year from the date of the order. Depending on the terms of the contract or operationally, undelivered or backordered items may be canceled by either party at their discretion.

As of September 26, 2020, the Company's deferred revenue balance was $212.8 million. As of March 28, 2020, the Company's deferred revenue balance was $208.5 million. During the three months ended September 26, 2020, the Company recognized $50.9 million in revenues that were reflected in deferred revenue at the beginning of the period.

The table below represents aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of September 26, 2020:
September 26, 2020
(in millions) Current Noncurrent Total
Performance obligations $ 146.6  $ 68.4  $ 215.0 

Upon establishment of creditworthiness, the Company may extend credit terms to its customers which typically ranges between 30 and 90 days from the date of invoice depending on geographic region and type of customer. The Company typically bills upon product hardware shipment, at time of software activation or upon completion of services. Revenue is not generally recognized in advance of billings. The balance of contract assets as of September 26, 2020 was $4.3 million. As of March 28, 2020, the Company's contract assets balance was $3.7 million. None of the Company's contracts are deemed to have significant financing components.

Sales, value add, and other taxes collected concurrent with revenue producing activities are excluded from revenue.

38

Commercial distributors and retailers represent the Company's largest sources of net revenues. Sales through its distribution and retail channels are made primarily under agreements allowing for rights of return and include various sales incentive programs, such as back end rebates, discounts, marketing development funds, price protection, and other sales incentives. The Company has an established sales history for these arrangements and the Company records the estimated reserves at the inception of the contract as a reflection of the reduced transaction price. Customer sales returns are estimated based on historical data, relevant current data, and the monitoring of inventory build-up in the distribution channel. Revenue reserves represent a reasonable estimation made by management and are subject to significant judgment. Estimated reserves may differ from actual returns or incentives provided, due to unforeseen customer return or claim patterns or changes in circumstances. For certain customer contracts which have historically demonstrated variability, the Company has considered the likelihood of being under-reserved and has considered a constraint accordingly. Provisions for Sales Returns are presented within accrued liabilities in the Company's condensed consolidated balance sheets. Provisions for promotions, rebates, and other sales incentives are presented as a reduction of accounts receivable unless there is no identifiable right offset, in which case they are presented within accrued liabilities on its condensed consolidated balance sheets. See Note 5, Details of Certain Balance Sheet Accounts above for additional details.

For certain arrangements, the Company pays commissions, bonuses and taxes associated with obtaining the contracts. The Company capitalizes such costs if they are deemed to be incremental and recoverable. The Company has elected to use the practical expedient to record the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less. Determining the amortization period of costs related to obtaining a contract involves judgment. Capitalized commissions and related expenses, on hardware sales and services recognized at a point in time generally have an amortization period of less than one year. Maintenance-related performance obligations generally have an amortization period greater than one year when considering renewals. Capitalized commissions are amortized to Sales and Marketing Expense on a straight-line basis. The capitalized amount of incremental and recoverable costs of obtaining contracts with an amortization period of greater than one year are $4.7 million as of September 26, 2020. Amortization of capitalized contract costs for the three and six months ended September 26, 2020 was immaterial.

17. SEGMENT REPORTING AND GEOGRAPHIC INFORMATION

The Company's Chief Executive Officer is identified as its Chief Operating Decision Maker ("CODM"). The CODM has organized the Company, manages resource allocations and measures performance among its two operating segments — Products and Services.

The Products segment includes the Company's Headsets, Voice and Video product lines. The Services segment includes maintenance support on hardware devices as well as professional, managed and cloud services and solutions. In managing the two operating segments the CODM uses information about their revenue and gross margin after adjustments to exclude certain non-cash transactions and activities that are not reflective of the Company's ongoing or core operations as further described below. The CODM does not review asset information by segment.

Purchase accounting amortization: Represents the amortization of purchased intangible assets recorded in connection with the Acquisition of Polycom.

Deferred revenue purchase accounting: Represents the impact of fair value purchase accounting adjustments related to deferred revenue recorded in connection with the Acquisition of Polycom. The Company's deferred revenue primarily relates to Service revenue associated with non-cancelable maintenance support on hardware devices which are typically billed in advance and recognized ratably over the contract term as those services are delivered. This adjustment represents the amount of additional revenue that would have been recognized during the period absent the write-down to fair value required under purchase accounting guidelines.

Acquisition and integration fees: Represents charges incurred in connection with the Acquisition and integration of Polycom such as system implementations, legal and accounting fees.

Stock compensation expense: Represents the non-cash expense associated with the Company's issuance of common stock and share-based awards to employees and non-employee directors.

39

The following table presents segments results for revenue and gross margin, as reviewed by the CODM, and their reconciliation to the Company's condensed consolidated GAAP results:
Three Months Ended Six Months Ended
(in thousands) September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Segment revenues as reviewed by CODM
Products $ 347,970  $ 395,606  $ 639,756  $ 778,978 
Services 67,236  74,627  136,252  151,181 
Total segment revenues as reviewed by CODM $ 415,206  $ 470,233  $ 776,008  $ 930,159 
Segment gross profit as reviewed by CODM
Products $ 156,627  $ 198,104  $ 290,869  $ 404,796 
Services 46,274  48,315  92,517  98,364 
Total segment gross profit as reviewed by CODM $ 202,901  $ 246,419  $ 383,386  $ 503,160 
Three Months Ended Six Months Ended
(in thousands) September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019
Total segment revenues as reviewed by CODM $ 415,206  $ 470,233  $ 776,008  $ 930,159 
Deferred revenue purchase accounting (4,237) (8,524) (9,319) (20,683)
Consolidated GAAP net revenues $ 410,969  $ 461,709  $ 766,689  $ 909,476 
Total segment gross profit as reviewed by CODM (1)
$ 202,901  $ 246,419  $ 383,386  $ 503,160 
Purchase accounting amortization (17,176) (30,716) (35,414) (60,716)
Deferred revenue purchase accounting (4,237) (8,524) (9,319) (20,683)
Integration and rebranding costs —  (111) —  (1,069)
Stock-based compensation (742) (997) (1,575) (1,975)
Consolidated GAAP gross profit $ 180,746  $ 206,071  $ 337,078  $ 418,717 
(1) Includes depreciation expense of $3.6 million for both the three months ended September 26, 2020 and September 28, 2019. Includes depreciation expense of $6.9 million and $7.3 million for the six months ended September 26, 2020 and September 28, 2019.


18. SUBSEQUENT EVENTS

None.

40

Quantitative and Qualitative Disclosures About Market Risk

The discussion of our exposure to market risk related to changes in interest rates and foreign currency exchange rates contains forward-looking statements that are subject to risks and uncertainties.  Actual results could vary materially as a result of a number of factors including those discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended March 28, 2020, filed with the SEC on June 8, 2020, which could materially affect our business, financial position, or future results of operations.

Except as described below, there have been no material changes in our market risk as described in our Annual Report on Form 10-K for the fiscal year ended March 28, 2020.

INTEREST RATE RISK

Our exposure to market risk for changes in interest rates relates primarily to our floating-rate interest payments under our $1.275 billion term loan facility. In connection with the Acquisition, we entered into a Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto (the “Credit Agreement”). Borrowings under the Credit Agreement bear interest at a variable rate equal to (i) LIBOR plus a specified margin, or (ii) the base rate (which is the highest of (a) the prime rate publicly announced from time to time by Wells Fargo Bank, National Association, (b) the federal funds rate plus 0.50% or (c) the sum of 1% plus one-month LIBOR plus a specified margin.

On July 30, 2018, we entered into a 4-year amortizing interest rate swap agreement with Bank of America, N.A. as part of our overall strategy to manage our exposure to market risks associated with fluctuations in interest rates on the $1.275 billion term loan facility. As a matter of policy, we only enter into transactions that we believe will be highly effective at offsetting the underlying risk, and we do not use derivatives for trading or speculative purposes. Our objective is to mitigate the impact of interest expense fluctuations on our profitability related to interest rate changes by minimizing movements in future debt payments with this interest rate swap.

The swap has an initial notional amount of $831 million and matures on July 31, 2022. The swap involves the receipt of floating-rate interest payments for fixed interest rate payments over the life of the agreement. We have designated this interest rate swap as a cash flow hedge, the effective portion of changes in the fair value of the derivative is recorded to other comprehensive income (loss) on the accompanying balance sheets and reclassified into interest expense over the life of the agreement. We will review the effectiveness of this instrument on a quarterly basis, recognize current period hedge ineffectiveness immediately in earnings and will discontinue hedge accounting if we no longer consider hedging to be highly effective. For additional details, refer to Note 13, Derivatives, of the accompanying notes to condensed consolidated financial statements. During the six months ended September 26, 2020, we made payments of approximately $6.9 million on our interest rate swap and recognized $7.3 million within interest expense on the condensed consolidated statement of operations. As of September 26, 2020, we had $1.0 million of interest accrued within accrued liabilities on the condensed consolidated balance sheet. We had an unrealized pre-tax loss of approximately $15.9 million recorded within accumulated other comprehensive income (loss) as of September 26, 2020. A hypothetical 10% increase or decrease on market interest rates related to our outstanding term loan facility could result in a corresponding increase or decrease in annual interest expense of approximately $0.1 million.

Interest rates were lower in the three and six months ended September 26, 2020 compared to the same period in the prior year. In the three and six months ended September 26, 2020 and September 28, 2019 we generated interest income of $0.2 million and $0.2 million and $0.2 million and $0.5 million, respectively.

FOREIGN CURRENCY EXCHANGE RATE RISK

We are a net receiver of currencies other than the USD. Accordingly, changes in exchange rates, and in particular a strengthening of the USD, could negatively affect our net revenues and gross margins as expressed in USD. There is a risk that we will have to adjust local currency product pricing due to competitive pressures if there is significant volatility in foreign currency exchange rates.

41

Table of Contents
The primary currency fluctuations to which we are exposed are the Euro ("EUR"), British Pound Sterling ("GBP"), and the Chinese Renminbi ("RMB"). We use a hedging strategy to diminish, and make more predictable, the effect of currency fluctuations. All of our hedging activities are entered into with large financial institutions, which we periodically evaluate for credit risks. We hedge our balance sheet exposure by hedging EUR and GBP denominated cash, accounts receivable, and accounts payable balances, and our economic exposure by hedging a portion of anticipated EUR and GBP denominated sales. We can provide no assurance that our strategy will be successful in the future or that exchange rate fluctuations will not materially adversely affect our business. We do not hold or issue derivative financial instruments for speculative trading purposes.

The impact of changes in foreign currency rates recognized in other income and (expense), net was immaterial in both the three and six months ended September 26, 2020 and September 28, 2019. Although we hedge a portion of our foreign currency exchange exposure, the weakening of certain foreign currencies, particularly the EUR and GBP in comparison to the USD, could result in material foreign exchange losses in future periods.

Non-designated Hedges

We hedge our EUR and GBP denominated cash, accounts receivable, and accounts payable balances by entering into foreign exchange forward contracts. The table below presents the impact on the foreign exchange gain (loss) of a hypothetical 10% appreciation and a 10% depreciation of the USD against the forward currency contracts as of September 26, 2020 (in millions):
Currency - forward contracts Position USD Value of Net Foreign Exchange Contracts Foreign Exchange Gain From 10% Appreciation of USD Foreign Exchange Loss From 10% Depreciation of USD
EUR Sell EUR $ 59.1  $ 5.9  $ (5.9)
GBP Sell GBP $ 4.6  $ 0.5  $ (0.5)

Cash Flow Hedges

In the six months ended September 26, 2020, approximately 50% of our net revenues were derived from sales outside of the U.S. and denominated primarily in EUR and GBP.

As of September 26, 2020, we had foreign currency put and call option contracts with notional amounts of approximately €60.7 million and £12.3 million denominated in EUR and GBP, respectively. Collectively, our option contracts hedge against a portion of our forecasted foreign currency denominated sales. If the USD is subjected to either a 10% appreciation or 10% depreciation versus these net exposed currency positions, we could realize a gain of $4.1 million or incur a loss of $7.0 million, respectively.

The table below presents the impact on the Black-Scholes valuation of our currency option contracts of a hypothetical 10% appreciation and a 10% depreciation of the USD against the indicated open option contract type for cash flow hedges as of September 26, 2020 (in millions):
Currency - option contracts USD Value of Net Foreign Exchange Contracts Foreign Exchange Gain From 10% Appreciation of USD Foreign Exchange Loss From 10% Depreciation of USD
Call options $ 88.5  $ 1.2  $ (5.8)
Put options $ 81.4  $ 3.6  $ (0.5)
Forwards $ 73.6  $ 7.4  $ (7.4)


42

Table of Contents
Controls and Procedures

(a)Evaluation of disclosure controls and procedures

Our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 (i) is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

(b)Changes in internal control over financial reporting

There have been no changes in the Company’s internal control over financial reporting during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

PART II -- OTHER INFORMATION

LEGAL PROCEEDINGS

We are presently engaged in various legal actions arising in the normal course of business. We believe that it is unlikely that any of these actions will have a material adverse impact on our operating results; however, because of the inherent uncertainties of litigation, the outcome of any of these actions could be unfavorable and could have a material adverse effect on our financial condition, results of operations or cash flows. For additional information about our material legal proceedings, please see Note 7, Commitments and Contingencies, of the accompanying notes to the condensed consolidated financial statements.

RISK FACTORS

You should carefully consider the risk factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended March 28, 2020, filed with the SEC on June 8, 2020 (the "Form 10-K"), each of which could materially affect our business, financial position, or future results of operations. Except as described below, there have been no material changes to the risk factors included in the Form 10-K.

The risks described here and in the Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial position, or future results of operations.

43

Table of Contents

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table presents information with respect to repurchases of our common stock made by us during the second quarter of fiscal year 2021:
 
Total Number of Shares Purchased 1
 
Average Price Paid per Share 2
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs 1
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs 3
June 28, 2020 to July 25, 2020 3,170  4 N/A —  1,369,014 
July 26, 2020 to August 22, 2020 3,800  4 N/A —  1,369,014 
August 23, 2020 to September 26, 2020 15,201  4  N/A —  1,369,014 
1  On November 28, 2018, our Board of Directors approved a 1 million shares repurchase program expanding our capacity to repurchase shares to approximately 1.7 million shares. We may repurchase shares from time to time in
open market transactions or through privately negotiated transactions. There is no expiration date associated with the repurchase activity.
2  "Average Price Paid per Share" reflects open market repurchases of common stock only.
3  These shares reflect the available shares authorized for repurchase under the expanded program approved by the Board on November 28, 2018.
4  Represents only shares that were tendered to us in satisfaction of employee tax withholding obligations upon the vesting of restricted stock grants under our stock plans.
44

Table of Contents

MINE SAFETY DISCLOSURES

Not applicable.

OTHER INFORMATION

None.

EXHIBITS

We have filed the following documents as Exhibits to this Form 10-Q:
Exhibit Number     Incorporation by Reference Filed Herewith
Exhibit Description   Form File No. Exhibit Filing Date
10.1 X
10.2 X
10.3 X
31.1           X
31.2           X
             
32.1           X
             
101.INS XBRL Instance Document - the XBRL Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document           X
             
101.SCH Inline XBRL Taxonomy Extension Schema Document           X
             
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document           X
             
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document           X
             
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document           X
101.DEF Inline XBRL Taxonomy Definition Linkbase Document X
104 Cover Page Interactive Data File, (formatted as Inline XBRL and contained in Exhibit 101) X

45

Table of Contents
Plantronics, Inc.
FORM 10-Q
CROSS REFERENCE TABLE
Item Number Page(s)
PART I. FINANCIAL INFORMATION
 
15
-
40
4
-
14
41
-
43
43
PART II. OTHER INFORMATION
43
43
44
45
45
47
46

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
  PLANTRONICS, INC.
     
Date: October 29, 2020 By: /s/ Charles D. Boynton
  Name: Charles D. Boynton
  Title: Executive Vice President and Chief Financial Officer
47






345 Encinal Street
Santa Cruz, CA 95060
www.poly.com



August 14, 2020

Mary Huser
511 West Santa Inez Avenue
Hillsborough, CA 94010


Re: Mutual Separation Agreement and Release

Dear Mary:

Consistent with our recent discussions to mutually transition your role as the Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary and to transition your responsibilities to another executive as the Chief Executive Officer shall designate, this letter agreement (“Letter Agreement”) confirms that your employment with Plantronics, Inc. and its affiliates (also branded as “Poly”) (collectively, the “Company”) is terminating based on our mutual agreement. We hope that the information contained in this Letter Agreement will help you to transition to other opportunities.

This Letter Agreement summarizes the terms of your separation from the Company and release between you and the Company. The purpose of this Letter Agreement is to establish an amicable arrangement for ending your employment relationship, for you to release the Company of any claims and to resolve any disputes you may have with the Company regarding your employment or separation from that employment, and to permit you to receive compensation to the extent specified below. With these understandings, and in exchange for the promises of you and the Company as set forth below, you and the Company agree as follows:

Terms Related To Employment Separation

1.Employment Status: Your employment will end on August 14, 2020 (“Separation Date”). On the Separation Date you will be paid all of your wages earned, but unpaid, through the Separation Date.
2.Reaffirmation of Prior Agreements: You reaffirm your commitment under any prior agreements you signed with the Company, including the Employee Patent, Secrecy and Invention Agreement (“EPSIA”)/Employee Confidential Information and Invention Assignment Agreement (“ECIIAA”), and any successor thereto (all prior agreements you entered into with the Company, including the Equity Agreements as defined below, but excluding your Executive Severance Agreement dated June 15, 2018 and your Change of Control Severance Agreement dated November 5, 2018, are collectively referred to here as the “Company Agreements”). As part of this Letter Agreement, you will comply fully with the terms of the Company Agreements. You also confirm that you have not violated any Company Agreements.



3.Board, Officer, and/or Director Positions: You agree that you will resign as of the date of this Letter Agreement from all Company boards and/or Officer or Director positions, and pursuant to such resignation and this Letter Agreement confirms that your authority and responsibility for any Company “policymaking function” (as that term is used in Rule 16a-1 to the Rules and Regulations to the Securities Exchange Act of 1934) immediately ceases upon your resignation from these positions. In addition, any indemnification related to time served in those positions will remain for the time served in those positions prior to the Separation Date.
4.Company Property: You agree that on or before the Separation Date, you will return to the Company all Company property and materials, including but not limited to (if applicable), phones, video or voice equipment, sample products, computers, laptops, fax machines, scanners, copiers, cellular phones, Company credit cards and telephone charge cards, manuals, building keys and passes, courtesy parking passes, USB or other removable drives, hard drives, software programs and data compiled with the use of those programs, software passwords or codes, tangible copies of trade secrets and confidential information, sales forecasts, names and addresses of Company customers and potential customers, customer lists, customer contacts, sales information, sales forecasts, memoranda, sales brochures, business or marketing plans, reports, projections, and any and all other information or property previously or currently held or used by you that is or was related to your employment with the Company (“Company Property”). You agree that in the event that you discover any other Company Property in your possession after your Separation Date, you will immediately return such materials to the Company.
5.Proprietary Information: You also acknowledge that in your role with the Company, you may have had access to and received information which is confidential and proprietary to the Company (“Proprietary Information”). You agree to keep all such Proprietary Information strictly confidential, and not to share this information with subsequent employers, competitors or any other person. You agree the Company has no adequate remedy at law if you violate the terms of this confidentiality provision. In such event, the Company will have the right, in addition to any other right it may have, to seek injunctive relief to restrain any breach or threatened breach by you. You agree to defend, indemnify and hold the Company harmless from and against all claims, actions, damages, losses and liabilities, including reasonable attorneys’ fees and expenses, arising out of any breach of your obligations under this provision. Nothing in this Letter Agreement is intended to discourage or restrict you from reporting any theft of Trade Secrets pursuant to the Defend Trade Secrets Act of 2016 (“DTSA”) or other applicable state or federal law. The DTSA prohibits retaliation against an employee because of whistleblower activity in connection with the disclosure of Trade Secrets, so long as any such disclosure is made either (i) in confidence to an attorney or a federal, state, or local government official and solely to report or investigate a suspected violation of the law, or (ii) under seal in a complaint or other document filed in a lawsuit or other proceeding. If you believe that any employee or any third party has misappropriated or improperly used or disclosed Trade Secrets or Confidential Information, you should report such activity to EVP, Chief Human Resources Officer, 345 Encinal St., Santa Cruz, CA 95060. This Letter Agreement is in addition to and not in lieu of any obligations to protect the Company’s Proprietary Information pursuant to the Employee Handbook or other written policies of the Company. Nothing in this Letter Agreement shall limit, curtail or diminish the Company’s statutory rights under the DTSA, any applicable state law regarding trade secrets or common law.
6.Final Pay: On or about the Separation Date, you will receive your final base pay (subject to applicable tax withholdings and other deductions) attributable to services performed but not yet paid through the Separation Date. You agree that you will submit to the Company all final requests for







reimbursement of any business expenses you were required to incur in performing your job for the Company prior to your Separation Date in accordance with applicable Company policy. You understand and agree that all such reimbursements will be subject to the terms and conditions of the Company’s then current Travel and Expense Reimbursement policy and other applicable policies and procedures.

7.Benefits & Benefit Plan Participation: All employee benefits and participation in the Company’s benefits and group benefit plans will end on the Separation Date, except that your medical insurance benefits will continue through the end of the month in which you terminate employment, if permitted under the terms of the applicable health plan. Thereafter, you will have the right to continue participating in the Company’s group health plans under the federal law known as “COBRA,” provided that you timely elect COBRA continuation coverage and timely pay the full COBRA premium due following the period of time set forth in Section 10(b) below that the Company ceases payment of such premium. A notice of your rights under COBRA, COBRA premium information and COBRA election form(s) will be sent to your home address on file with the Company.
8.Equity: Your stock options, restricted stock, restricted stock units, performance stock units and any underlying shares of Plantronics, Inc. stock remain subject to the terms and conditions of the applicable agreement(s) signed by you and the terms and conditions of the Company’s 2003 Stock Plan (the “Equity Agreements”). The Company acknowledges that your “service” for all purposes under the Equity Agreements will continue uninterrupted until your Separation Date. Please see the Stock Closing Statement contained in your exit packet for a report regarding the status of your equity awards.
9.Stock Trading: You may continue to sell vested shares acquired through equity awards or the ESPP through your E*TRADE account at www.etrade.com/stockplans. If you need phone assistance with your transaction, you may reach E*TRADE at (800) 838-0908 or (650) 599-0125. You will be required to obtain pre-clearance for three (3) months after your Separation Date. You may sell vested shares during open window periods as long as you are not in possession of material non-public information during the open window periods. You may not sell during our closed windows during this three (3) month time period. After the three (3) months expires, you may sell during any open or closed window period as long as you are not in possession of material non-public information.

Terms Related To Consideration and Release Agreement

10.Consideration: Excluding the pay and benefits set forth above, you are not otherwise entitled to receive any compensation from the Company. However, in gratitude for your service and in exchange for, and in consideration of, your full execution and return of this Letter Agreement within twenty-one (21) days from the date of this Letter Agreement, and provided that you do not revoke the Letter Agreement under Section 13 below, the Company will pay or provide as follows (the “Consideration”):

a.Cash Consideration: The Company will pay you a lump sum cash payment equal to
$442,520, less applicable withholding or deductions, on the first Company payroll date following the completion of the Revocation Period (as defined in Section 13 below).

b.COBRA: The Company will pay for your COBRA continuation coverage for twelve
(12) months from the Separation Date (calculated from the first day of the month following your Separation Date), provided you timely sign up for COBRA benefits when you receive the COBRA






materials from the COBRA administrator, and provided you remain eligible for such coverage. All COBRA costs after the twelve (12) month period shall be paid by you on a monthly basis for as long as, and to the extent that, you remain eligible for COBRA continuation coverage.

c.Outplacement: The Company agrees to provide you standard outplacement services in a manner as determined by the Company for a twelve (12)-month period of time. This benefit must be initiated by you within three (3) months of signing this Letter Agreement. No cash payment will be made in lieu of such services.

Each component of the Consideration described above, in all cases, will be subject to (i) any required tax withholdings, (ii) any garnishment, support or withholding orders required by law, and (iii) any debt obligation you owe to the Company as of the Separation Date.

11.Release: In exchange for the Consideration and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, you agree as follows:

a.You and your representatives, agents, estate, heirs, successors and assigns, absolutely and unconditionally hereby release, remise, discharge, and hold harmless the Company Releasees (“Company Releasees” defined to include the Company and/or any of its parents, subsidiaries or affiliates, predecessors, successors or assigns, and its and their respective current and/or former partners, directors, shareholders/stockholders, officers, employees, employee benefit plans, insurers, attorneys and/or agents, all both individually and in their official capacities), from any and all legally waivable actions or causes of action, suits, claims, complaints, contracts, liabilities, agreements, promises, torts, debts, damages, controversies, judgments, rights and demands, whether existing or contingent, known or unknown, suspected or unsuspected, which arise out of your employment with, change in employment status with, and/or separation of employment from, the Company. This release is intended by you to be all-encompassing and to act as a full and total release of any legally waivable claims, whether specifically enumerated herein or not, that you may have or have had against the Company Releasees arising from conduct occurring up to and through the date you signed this Letter Agreement, including, but not limited to, any legally waivable claims arising from any federal, state or local law, regulation or constitution dealing with either employment, employment benefits or employment discrimination including any claims or causes of action you have or may have relating to discrimination under federal, state or local statutes including, but not limited to, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act of 1990, Title VII of the Civil Rights Act of 1964, the Employee Retirement Income Security Act of 1974, the Americans with Disabilities Act, the Family and Medical Leave Act, the California Fair Employment and Housing Act, the Fair Labor Standards Act, the California Labor Code, all as amended from time to time, any contract, whether oral or written, express or implied; any tort; any claim for equity or other benefits; or any other statutory and/or common law claim.

b.You acknowledge that your execution of this Letter Agreement shall be effective as a bar to each and every claim specified in Section 11(a) of this Letter Agreement. Accordingly, you hereby expressly waive any and all rights and benefits conferred upon you by the provisions of Section 1542 of the California Civil Code (or analogous statute(s) from any other state) and expressly consent that this Letter Agreement shall be given full force and effect with respect to each and all of its express terms and provisions, including those related to unknown and/or unsuspected claims, if any, as well as those relating to any other claims specified in Section 11(a) of this Letter Agreement. Section 1542 provides as follows:







“A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release, and that if known by him or her would have materially affected his or her settlement with the debtor or released party.”

You further represent that you understand and acknowledge the significance and consequence of such release as well as the specific waiver of Section 1542.

c.The release in this Section of this Letter Agreement does not include any claim which, as a matter of law, cannot be released by private agreement, or relates to indemnification protection under the Company’s Articles of Incorporation or Bylaws, pursuant to contract or applicable law. Further, as described in the following Section, this release does not prevent or prohibit you from filing a claim with a federal, state or local government agency that is responsible for enforcing a law on behalf of the government.

12.Government Agency Claims: Nothing in this Letter Agreement, including the release or the Non-disparagement or Confidentiality provisions below restricts or prohibits you from initiating communications directly with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity, including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Department of Justice, the Securities and Exchange Commission, the Congress, the California Department of Fair Employment and Housing, or any other federal, state or local government agency (collectively, the “Regulators”), or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation. However, to the maximum extent permitted by law, you are waiving your right to receive any individual monetary relief from the Company or any others covered by the release resulting from such claims or conduct, regardless of whether you or another party has filed them, and in the event you obtain such monetary relief the Company will be entitled to an offset for the payments made pursuant to this Letter Agreement. This Letter Agreement does not limit your right to receive an award from any Regulator that provides awards for providing information relating to a potential violation of law. You do not need the prior authorization of the Company to engage in conduct protected by this paragraph, and you do not need to notify the Company that you have engaged in such conduct. Please take notice that federal law provides criminal and civil immunity to federal and state claims for trade secret misappropriation to individuals who disclose a trade secret to their attorney, a court, or a government official in certain, confidential circumstances that are set forth at 18 U.S.C. Sections 1833(b)(1) and 1833(b)(2), related to the reporting or investigation of a suspected violation of the law, or in connection with a lawsuit for retaliation for reporting a suspected violation of the law.

13.Waiver of Rights and Claims Under the Age Discrimination in Employment Act of 1967:

As required by federal law, you are being informed that you have or may have specific rights under the Age Discrimination in Employment Act of 1967 (“ADEA”) and you agree that:

a.in consideration for the Consideration, which you are not otherwise entitled to receive, you specifically and voluntarily waive all rights and claims under the ADEA you might have against the Company Releasees to the extent such rights and/or claims arose prior to the date this Letter Agreement was executed;






b.you are advised that you have twenty-one (21) days within which to consider the terms of this Letter Agreement and to consult with or seek advice from an attorney of your choice or any other person of your choosing prior to executing this Letter Agreement. The twenty-one (21)-day review period will not be affected or extended by any revisions, whether material or immaterial, that might be made to this Letter Agreement;

c.you have carefully read and fully understand all of the provisions of this Letter Agreement, and you knowingly and voluntarily agree to all of the terms set forth in this Letter Agreement;

d.you have seven (7) days after you sign this Letter Agreement to revoke your acceptance of it (“Revocation Period”). If you choose to revoke it timely, the Letter Agreement will be null and void and the Letter Agreement shall not be valid or enforceable. To revoke, you must deliver a signed writing stating your intention to revoke the Letter Agreement and the writing must be delivered to EVP, Chief Human Resources Officer, 345 Encinal St., Santa Cruz, CA 95060, by or before the end of the Revocation Period; and

e.in entering into this Letter Agreement you are not relying on any representation, promise or inducement made by the Company or its attorneys with the exception of those promises described in this document.

14.Non-disparagement: Except as described in Section 12, and not including any testimony given truthfully under oath or as required by any other legal proceeding, you agree not to make disparaging, critical or otherwise detrimental comments to any person or entity concerning the Company, its officers, directors or employees; the products, services or programs provided or to be provided by the Company; the business affairs, operation, management or the financial condition of the Company; or the circumstances surrounding your employment and/or separation of employment from the Company. Similarly, the Company agrees, and agrees to inform its executive officers and members of its Board of Directors that they are bound through the Company’s agreement in this regard (but only for so long as each officer or member is an employee or director of the Company), not to make disparaging, critical or otherwise detrimental comments to any person or entity concerning you or your relationship with the Company.

15.Confidentiality: Except as described in Section 12 and disclosed in any regulatory filings the Company files with the Securities and Exchange Commission, you agree that you will not disclose to others the fact or terms of this Letter Agreement, except that you may disclose such information to your attorney or accountant in order for such individuals to render services to you.

16.Cooperation: Except as described in Section 12, you agree to make yourself reasonably available to the Company to respond to requests by the Company for information pertaining to or relating to the Company and/or its subsidiaries, affiliates, partners, directors, officers, agents or employees that may be within your knowledge. Moreover, you agree to cooperate fully with and otherwise reasonably assist the Company, to the extent reasonable in light of your then-existing professional and personal obligations, in connection with any and all existing or future litigation or investigations, brought by or against, or any potential claim, litigation or investigations that may be made or threatened to be made against, the Company or any of its subsidiaries, affiliates, partners, directors, officers, agents or employees, whether administrative, civil or criminal in nature, in which and to the extent the Company deems your cooperation necessary.






17.No Filing of Claims: You represent and warrant that you do not presently have on file any claims, charges, grievances, actions, appeals or complaints against Company Releasees in or with any administrative, state, federal or governmental entity, agency, board or court, or before any other tribunal or arbitrator(s), public or private, based upon any actions occurring prior to the date of this Letter Agreement.

18.Tax Compliance: Notwithstanding anything to the contrary herein, the following provisions apply to the extent payments provided herein are subject to section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and other guidance thereunder and any state law of similar effect (collectively, “Section 409A”). Payments that are payable upon your termination of employment, if any, shall not commence until you have a “separation from service” for purposes of Section 409A. Each installment of payments hereunder is a separate “payment” for purposes of Section 409A, and the benefits payable under this Letter Agreement are intended to satisfy the exemptions from application of Section 409A provided under Treasury Regulations Sections 1.409A-1(b)(4) and 1.409A-1(b)(9). However, if such exemptions are not available and you are, upon separation from service, a “specified employee” for purposes of Section 409A, then, solely to the extent necessary to avoid adverse personal tax consequences under Section 409A, the timing of the payments shall be delayed until the earlier of (a) six (6) months and one day after your separation from service, or (b) your death. Except to the minimum extent that payments must be delayed because you are a “specified employee,” all amounts will be paid as soon as practicable in accordance with the Company’s normal payroll practices pursuant to the payment schedule set forth in this Letter Agreement. If and to the extent that reimbursements or other in-kind benefits under this Letter Agreement constitute “nonqualified deferred compensation” for purposes of Section 409A, such reimbursements or other in- kind benefits shall be made or provided in accordance with the requirements of Section 409A. You will be solely responsible for any tax imposed under Section 409A and in no event will the Company have any liability with respect to any tax, interest or other penalty imposed under Section 409A.

19.Certain Covenants and Representations; Governing Law:

a.You acknowledge that you have carefully read and fully understand all of the provisions of this Letter Agreement, and you knowingly and voluntarily agree to all of the terms set forth in this Letter Agreement; and in entering into this Letter Agreement you are not relying on any representation, promise or inducement made by the Company or its attorneys with the exception of those promises described in this document.

b.Except as explicitly provided herein, this Letter Agreement sets forth the complete and sole agreement between the parties and supersedes any and all other agreements or understandings, whether oral or written, between you and the Company, including for the avoidance of doubt your Executive Severance Agreement dated June 15, 2018 and your Change of Control Severance Agreement dated November 5, 2018. As such, the Company Agreements and the Equity Agreements referenced herein shall remain in full force and effect in accordance with their respective terms. This Letter Agreement may not be changed, amended, modified, altered or rescinded except upon the express written consent of both the CEO of the Company and you.

c.If any provision of this Agreement, or part thereof, is, to any extent, held illegal, invalid, incapable of being enforced, void or voidable as against public policy, or otherwise, such provision, or part thereof, shall be excluded to the extent of such invalidity or unenforceability and all other provisions of this Agreement shall remain in full force and effect; and, to the extent permitted and possible, the invalid or unenforceable provision, or part thereof, shall be deemed replaced by a






provision that is valid and enforceable and that comes closest to expressing the intention of such invalid or unenforceable term. Moreover, if a court declines to amend this Agreement as provided herein, the invalidity or unenforceability of any provision of this Agreement, or part thereof, shall not affect the validity or enforceability of the remaining provisions, which shall be enforced as if the offending provision had not been included in this Agreement. To this extent, the provisions and parts thereof of this Agreement are declared to be severable. Any claims arising out of this Letter Agreement (or any other claims arising out of the relationship between the parties) shall be governed by and construed in accordance with the laws of the State of California and shall in all respects be interpreted, enforced and governed under the internal and domestic laws of California, without giving effect to the principles of conflicts of laws of such state.

d.ARBITRATION: THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS LETTER AGREEMENT, THEIR INTERPRETATION AND ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO BINDING ARBITRATION BEFORE JAMS PURSUANT TO THE THEN CURRENT EXPEDITED RULES OF JAMS UNDER ITS RULE FOR RESOLUTION OF EMPLOYMENT DISPUTES. THE RULES OF JAMS CAN BE FOUND AT www.jamsadr.org. THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE AND BINDING ON THE PARTIES TO THE ARBITRATION. THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY. HOWEVER, EITHER PARTY MAY BRING A CLAIM IN COURT FOR PRELIMINARY INJUNCTIVE RELIEF ONLY ARISING OUT OF A BREACH BY THE OTHER PARTY OF THE EMPLOYEE PATENT SECRECY AGREEMENT SIGNED BY YOU.

e.This Letter Agreement shall not be construed as an admission by you or the Company of any wrongful act, unlawful discrimination, or breach of contract.

f.You acknowledge that, together with damages and any other relief that may be appropriate, you will be subject to a permanent injunction and/or temporary restraining order for any violations of this Letter Agreement, including any violations of any Company Agreements. In the event that the Company prevails in any action brought by the Company to enforce any provision of this Agreement or any Company Agreements (including but not limited to an action for a permanent injunction or a temporary restraining order), you agree that you will pay the Company’s costs, including attorneys’ fees, in addition to any other damages or amounts that may be awarded.

g.You may not assign any of your rights or delegate any of your duties under this Letter Agreement. The rights and obligations of the Company shall inure to the benefit of the Company’s successors and assigns.

h.The failure or any delay on the part of the Company to exercise any right, remedy, power or privilege under this Letter Agreement shall not operate as a waiver thereof, nor shall any single or partial exercise of any right preclude any other or further exercise of the same or of any other right, nor shall any waiver of any right with respect to any occurrence be construed as a waiver of such right with respect to any other occurrence.

i.This Letter Agreement may be executed in two or more counterparts, each of which will be deemed an original, but all of which taken together will constitute one and the same instrument.







If this Letter Agreement correctly states the agreement and understanding we have reached, please indicate your acceptance by countersigning the enclosed copy and returning it to EVP, Chief Human Resources Officer, 345 Encinal St., Santa Cruz, CA 95060 no later than twenty-one (21) days from the date of this Letter Agreement.


Plantronics, Inc.


By: /s/ Anja Hamilton                  Name: Anja Hamilton
Title: EVP, Chief Human Resources Officer











































I REPRESENT THAT I HAVE READ THE FOREGOING LETTER AGREEMENT, THAT I FULLY UNDERSTAND THE TERMS AND CONDITIONS OF SUCH LETTER AGREEMENT AND THAT I AM KNOWINGLY AND VOLUNTARILY EXECUTING THE SAME WITHOUT DURESS OR COERCION FROM ANY SOURCE. IN ENTERING INTO THIS LETTER AGREEMENT, I DO NOT RELY ON ANY REPRESENTATION, PROMISE OR INDUCEMENT MADE BY THE COMPANY OR ITS REPRESENTATIVES WITH THE EXCEPTION OF THE CONSIDERATION DESCRIBED IN THIS DOCUMENT.


Accepted and Agreed to:





/s/ Mary Huser
Mary Huser

Date: 8/14/2020


345 Encinal Street
Santa Cruz, CA 95060
+1 (831) 426-5858

poly.com



August15,2020



David Shull
900 S. Williams Street
Denver, Colorado 80209


Dear David:

On behalf of Plantronics, Inc., now branded as Poly, the "Company," I am pleased to offer you the position of President and Chief Executive Officer, reporting directly to the Poly Board of Directors (the "Board"). Should you accept this offer of employment, your first day of employment is anticipated to be on or about September 9, 2020 (your actual first day of employment is referred to as the "start date"). Your principal place of employment will be the Company's offices located in Santa Cruz, California. You agree to use your best efforts to work at the Santa Cruz offices five days per week, except for vacation/sick periods, Company holidays, and travel and visits to other Company offices and facilities as reasonably required to attend to the Company's business.

This letter outlines the terms of your employment with the Company as of your start date, including your compensation and benefits, as set forth below:

Board
You will be appointed to serve as a member of the Board effective as of the start date. Thereafter, at each annual meeting of the Company's stockholders while you are the Company's President and Chief Executive Officer upon which your term as a Board member is scheduled to expire, the Company will nominate you to serve as a member of the Board. Your continued service as a member of the Board will be subject to any required stockholder approval. Upon the termination of your employment for any reason, unless otherwise requested by the Board, you will be deemed to have resigned from the Board (and all other positions held at the Company and its affiliates) voluntarily, without any further required action by you, as of the end of your employment and you, at the Board's request, will execute any documents necessary to reflect your resignation.
Membership
Annualized Base
$800,000 per year, payable biweekly in accordance with our standard payroll practices and less applicable tax withholding.
Salary
Annual Incentive
125% of your Annual Base Salary or $1,000,000, at target performance, with a maximum bonus opportunity of 200% of your Annual Base Salary, or $1,600,000, for outstanding performance. Any bonus you receive for fiscal year 2021 will reflect a pro-ration based on your start date.
Plan
The purpose of the Plantronics, Inc. Annual Incentive Plan (“AIP” or the “Plan”) is to focus participants on achieving annual Company-wide financial performance goals as well as product group, segment, or functional objectives and individual performance goals by providing the opportunity to receive annual cash payments based on accomplishments during the year.



Please refer to the Annual Incentive Plan "Administrative Guidelines" for further details on how bonuses may be earned.
Target Total Cash
Up to $1,800,000 per year based on the compensation elements shown above assuming at target performance. There is no guarantee that total cash compensation will be achieved.
Compensation
Signing Bonus
The Company will pay to you a Signing Bonus of $500,000, less applicable deductions and withholdings (the "Signing Bonus"). The Signing Bonus will be paid on your first paycheck following your start date.
New Hire
It will be recommended to the Company's Board of Directors or a sub-committee thereof that you receive an award of 75,000 shares of the Company's common stock in the form of a restricted stock unit award {"RSUs") to be awarded on the 15th day of the month following the month in which the start date occurs (the "Grant Date"). If approved, the price to you of the RSUs will be $0.00 and the RSUs will be awarded and subject to the Company's 2003 Stock Plan, as amended and restated (the "Equity Incentive Plan") and RSU agreement in effect at the time of grant (the "RSU Documents"). If approved, the RSUs will vest and be settled in three equal annual installments on the first, second and third anniversaries of the Grant Date, respectively, in accordance with the terms of the RSU Documents. Subject to any vesting acceleration that may be provided for in the RSU Documents and the Change of Control Severance Agreement, all vesting is subject to your continued employment on each applicable vesting date.
Restricted Stock
Units
New Hire
It will be recommended to the Company's Board of Directors or a sub-committee thereof that you receive an award of 250,000 shares of the Company's common stock in the form of performance stock unit awards ("PSUs") on the Grant Date with the performance period aligned to the FY21 performance-based Restricted Stock Unit ("PSU Plan") as summarized in Schedule A hereto. The number of PSUs that will ultimately vest will be subject to the provisions of the PSU Plan. If approved, the price to you of the PSUs will be $0.00 and the PSUs will be awarded and subject to the PSU Plan, the Equity Incentive Plan and the PSU agreement in effect at the time of grant (the "PSU Documents"). If approved, the PSUs will vest and be settled in accordance with the PSU documents. Subject to any vesting acceleration that may be provided for in the PSU Documents and the Change of Control Severance Agreement, all vesting is subject to your continued employment on each applicable vesting date.
Performance
Stock Units
Change-in-Control
You and the Company will enter into the Change of Control Severance Agreement in the form attached hereto as Exhibit A (the "Change of Control Severance Agreement"), to become effective as of the start date.
Benefits
Severance
You and the Company will enter into the Change of Control Severance Agreement to become effective as of the start date.
Benefits
General Benefits
You will be eligible to participate in the Company's benefit programs as available or that become available to other similarly situated employees of the Company, subject to the generally applicable terms and conditions of each program. The continuation or termination of each program will be at the discretion of the Company. Life, Medical, Dental and Disability coverage will begin on your start date.




Executive
You will be automatically enrolled in our Executive Health Exam Program, if and to the extent such program continues to remain in effect and is offered to other similarly situated executives of the Company. This program is aimed to give you guidance and direction on further health items to follow up on. To qualify you must schedule the appointment through the pre-identified network of doctors.
Physical Program
401(k)
You are eligible to join the Company's 401(k) plan, subject to the terms and condition of the plan document.
Non-Qualified
You will be eligible to participate in a non-qualified deferred compensation plan, subject to the terms and conditions of the plan document. An eligible participant may elect to defer prospective compensation not yet earned by submitting a Compensation Deferral Agreement during the enrollment periods. For more information regarding the Company's Deferred Compensation Plan, please see the Prospectus.
Deferred
Compensation
Plan
ESPP
You will be eligible to participate in the Company's Employee Stock Purchase Plan, subject to the terms of the plan.
Tax Preparation
The Company will reimburse you for your documented annual tax preparation expenses not to exceed $25,000 per year. Please see below for additional information regarding reimbursements.
Assistance
Legal Preparation
The Company will reimburse you for your documented legal expenses incurred in the negotiation and review of this offer letter and the related documentation, in an amount not to exceed $25,000 (the "legal fee reimbursement"). In addition, the Company will pay you an amount, determined by the Company, necessary to pay federal, state and local income and employment taxes incurred by you arising from the legal fee reimbursement, and arising from the payments made to you pursuant to this sentence (the "legal fee reimbursement gross-up payment"). The legal fee reimbursement gross-up payment will be calculated by the Company based on the withholding rates that Company has in effect for you at the time the legal fee reimbursement is made to you. Please see below for additional information regarding reimbursements.
Assistance
Company Policies
You agree to comply with all Company policies, including, for the avoidance of any doubt, any equity ownership guidelines, insider trading policies and compensation clawback policies currently in existence or that may be adopted by the Company during your employment.

This formal notification of our offer of employment is subject to the terms set forth in your Employment Application which you have submitted to the Company and is contingent upon satisfactory background verification, receipt of an original application, a final review of references, and the approval of the Compensation Committee of the Board of Directors.

As a condition of your employment, you will also be required to sign and comply with: David Shull • New Hire Certification - Prior Employer Confidential Information, which requires, among other things, you to certify that you may have had access to a prior employer's confidential, proprietary or trade secret information, you have not downloaded or otherwise transferred any of that information to any device, you or your prior employer have deleted that information from any of your devices and/or returned that information to your prior employer and you will not use any such information during your employment with the Company.






For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to the Company within three business days of your start date, or our employment relationship with you may be immediately terminated.

Before releasing certain export-controlled technology and software to you during your employment at the Company, the Company may be required to obtain an export license in accordance with United States law. The Company will inform you if an export license is needed. If an export license is required, then this offer of employment and/or your continued employment {if applicable) with the Company is contingent upon receipt of the export license or authorization, and the Company will have no obligation to employ you or provide you with any compensation or benefits until the export license or authorization is secure.

Please be aware that your employment with the Company is for no specified period and constitutes at-will employment. As a result, you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause, and with or without notice. We request that, in the event of resignation, you give the Company at least two weeks' prior notice.

You agree that, during the term of your employment with the Company, you will devote substantially all of your professional time to your responsibilities at the Company, and you will not engage in any other employment, occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any other activities that conflict with your obligations to the Company.

As a Company employee, you will be expected to abide by company rules and standards as presented in our Employee Handbook and our Worldwide Code of Business Conduct and Ethics.

As a condition of your employment, you will also be required to sign and/or otherwise comply with:

Employee, Confidential Information, and Invention Assignment Agreement which requires, among other provisions, (i) the assignment of patent, copyright and other intellectual property rights to any invention made during your employment at the Company, and (ii) non-disclosure of proprietary information.

Export Compliance: Before releasing certain export-controlled technology and software to you during your employment at the Company, the Company may be required to obtain an export license in accordance with United States law. The Company will inform you if an export license is needed. If an export license is required, then this offer of employment and/or your continued employment (if applicable) with the Company is contingent upon receipt of the export license or authorization, and the Company will have no obligation to employ you or provide you with any compensation or benefits until the export license or authorization is secure.

All payments and benefits under this letter are subject to applicable tax and other withholdings. To the extent that reimbursements or other in-kind benefits under this letter constitute "nonqualified deferred compensation" for purposes of Internal Revenue Code section 409A, (i) all expenses or other reimbursements hereunder shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by you, (ii) any right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (iii) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, and (iv) except as specifically provided herein or in the applicable reimbursement arrangement, any such reimbursements or in-kind benefits must be for expenses incurred and benefits provided during the your lifetime. In no event will the Company be held liable for any taxes, interest, penalties or other amounts owed by Employee under Code Section 409A.














To indicate your acceptance of the Company's offer of employment as stated above, please sign and date this letter in the space provided below. This letter sets forth the terms of your employment with the Company and supersedes any prior representations or agreements, whether written or oral. This letter, including, but not limited to, its at-will employment provision, may not be modified or amended except by a written agreement signed by the Chairman of the Leadership Development and Compensation Committee of the Board of Directors and you.

*---------




















































I look forward to working with you and having you as a member of the team!


Sincerely,
PLANTRONICS, INC.

/s/ Gregg Hammann
Gregg Hammann
Chairman of the Leadership Development and Compensation Committee
of the Board of Directors













Agreed to and accepted:

Signature:        /s/ David M. Shull

Printed Name:        David M. Shull


Received Offer Date:     August 15, 2020


Confirmed Start Date:     September 8, 2020



This offer expires one week from the date listed on the first page.
Please scan/email a signed copy to indicate acceptance of offer.














Schedule A
PSU Performance Terms

The performance period for the PSU will begin on the first day of the Company's 2021 fiscal year and will end on the last day of the Company's 2023 fiscal year. The number of PSUs eligible to vest will be determined proportionally at the end of fiscal years 2021, 2022 and 2023, based on Relative Total Shareholder Return against the iShares S&P North American Tech-Multimedia Networking Index {IGN). The Company's Total Stockholder Return will be compared against the Index Total Stockholder Return (each expressed as a growth rate percentage) to result in a growth rate (the "Growth Rate Delta") equal to the Company's Total Stockholder Return minus the Index Total Stockholder Return. The Growth Rate Delta will be calculated as of the Period End Date as shown in the table below. Capitalized terms used but not defined in this paragraph shall have the meanings set forth in the PSU Documents (as defined below).

Level Growth Rate Delta Percentage of Target Number of PSUs that Become Eligible PSUs Number of Eligible PSUs
1
>25%
200% Maximum Number of PSUs
2 0% 100% Target Number of PSUs
3
<-33%
0% 0

In the event of a Change in Control (as defined in the Equity Incentive Plan) that occurs prior to the completion of the Company's 2023 fiscal year, the number of Restricted Stock Units that become eligible to vest ("Eligible Restricted Stock Units") will be determined by the Compensation Committee in its sole discretion no later than five
(5) business days prior to the closing of the Change in Control {the "Closing"). The number of Eligible Restricted Stock Units that will vest on the Closing will be pro-rated by multiplying the calculated number of Eligible Restricted Stock Units by a fraction with a numerator equal to the number of completed calendar months that have elapsed between the first day of the Company's 2021 fiscal year and the Closing and a denominator equal to thirty-six (36). The remaining Eligible Restricted Stock Units will be scheduled to vest in equal installments on each annual anniversary of the first day of the Company's 2021 fiscal year such that 100% of the Eligible Restricted Stock Units will be vested on the last day of the Company's 2023 fiscal year, subject to your continuing to be a Service Provider (as defined in the Equity Incentive Plan) through such dates. Notwithstanding the foregoing, following the Closing, the Eligible Restricted Stock Units will be eligible for accelerated vesting upon a qualifying termination pursuant to the Change of Control Severance Agreement.

The foregoing is a summary of the PSU award and the actual terms and conditions of the PSU award will be set forth in the PSU Documents.


PLANTRONICS, INC.

CHANGE OF CONTROL SEVERANCE AGREEMENT

This Change of Control Severance Agreement (the "Agreement") is made and entered into by and between David Shull ("Key Associate") and Plantronics, Inc., a Delaware corporation (the "Company"), effective as of September 9, 2020 (the "Effective Date").

RECITALS

1.It is expected that the Company from time to time will consider the possibility of an acquisition by another company or other change of control. The Leadership Development and Compensation Committee (the "Committee") of the Board of Directors of the Company (the "Board") recognizes that such consideration can be a distraction to certain executives and can cause them to consider alternative employment opportunities. The Committee has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of Key Associate, notwithstanding the possibility, threat or occurrence of a Change of Control of the Company.

2.The Committee believes that it is in the best interests of the Company and its stockholders to provide Key Associate with an incentive to continue his employment prior to a Change of Control and to motivate Key Associate to maximize the value of the Company upon a Change of Control for the benefit of its stockholders.

3.The Committee believes that it is imperative to provide Key Associate with certain severance benefits upon Key Associate's termination of employment under certain circumstances. These benefits will provide Key Associate with enhanced financial security and incentive and encouragement to remain with the Company notwithstanding the possibility of a Change of Control.

4.Certain capitalized terms used in the Agreement are defined in Section 6 below.

AGREEMENT

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:

1.Term of Agreement. This Agreement shall have an initial term commencing on the Effective Date and ending on March 31, 2023 (the "Initial Term"); provided that, on March 31, 2023, and on each annual anniversary of such date (such date and each annual anniversary thereof shall be hereinafter referred to as the "Renewal Date"), unless previously terminated, the term of this Agreement shall be automatically extended for additional one (1) year terms (each an "Additional Term"), from year to year unless at least sixty (60) days prior to any Renewal Date, the Company shall give notice to Key Associate that the term of this Agreement shall not be so extended, in which case this Agreement shall terminate on such next March 31 (the "Expiration Date"). Notwithstanding the foregoing sentence, (a) if a Change of Control occurs at any time during either the Initial Term or an Additional Term, the term of this Agreement will extend automatically through the date that is twenty-four (24) months following the effective date of the Change of Control, or (b) if an initial occurrence of an act or omission by the Company constituting the grounds for "Good Reason" in accordance with Section 6(e) hereof has occurred (the "Initial Grounds"), and the expiration date of the Company cure period (as such term is used in Section 6(e)) with respect to such Initial Grounds could occur following the expiration of the Initial Term or an Additional Term, the term of this Agreement shall extend automatically through the date that is ninety (90) days following the expiration of such cure period, but such extension of the term will only apply with respect to the Initial Grounds. If Key Associate becomes entitled to benefits under Section 3 or Section 4 during the term of this Agreement, the Agreement will not terminate until all of the obligations of the parties hereto with respect to this Agreement have been satisfied.

2.At-Will Employment. The Company and Key Associate acknowledge that Key Associate's employment is and will continue to be at-will, as defined under applicable law. If Key Associate's employment




terminates for any reason, Key Associate will not be entitled to any payments, benefits, damages, awards or compensation other than as provided by this Agreement or as provided in any employment agreement entered into between the Company and Key Associate, and the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses.

3.Change of Control. In the event of a Change of Control, and subject to Key Associate's continued employment with the Company through the effective date of such Change of Control, all outstanding equity awards will vest according to the vesting schedule specified in the 2003 Stock Plan except as provided herein.

4.Severance Benefits.

(a)Termination without Cause or Resignation for Good Reason during the Change of Control Period. If the Company terminates Key Associate's employment with the Company without Cause or if Key Associate resigns from such employment for Good Reason, and such termination occurs during the Change of Control Period, and Key Associate signs and does not revoke a release of claims with the Company in substantially the form attached hereto as Exhibit A (the "Release") and provided that the Release becomes effective no later than sixty (60) days following the termination date or such earlier date required by the Release (such deadline, the "Release Deadline"), then subject to this Section 4, Key Associate will receive the following:

(i)Accrued Compensation. The Company will pay Key Associate all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to Key Associate under any Company-provided plans, policies, and arrangements.

(ii)Severance Payment. Key Associate will receive a lump-sum payment (less applicable withh1olding taxes) equal to the sum of (A) 200% of Key Associate's annual base salary as in effect immediately prior to Key Associate's termination date or (if greater) at the level in effect immediately prior to the Change of Control, plus (B) 200% of the higher of (1) the target bonus as in effect for the fiscal year in which the Change of Control occurs or (2) the target bonus as in effect for the fiscal year in which the termination occurs, plus (C) that pro-rata portion of Key Associate's annual incentive bonus as measured by the beginning of quarter ("BOQ") accrual for the incentive bonus Key Associate has earned but not yet been paid (disregarding the requirement that the participant must have been employed by the Company as of the date of payout to earn any portion of or all of their annual incentive bonus).

(iii)COBRA. Key Associate will receive a lump sum cash payment in an amount equal to the monthly Consolidated Omnibus Budget Reconciliation Act of 1985, as amended ("COBRA") premium that Key Associate would be required to pay to continue his group health coverage as in effect on the date of his termination for himself and his eligible dependents, multiplied by twenty-four (24), which payment will be made less applicable withholdings and regardless of whether Key Associate elects COBRA continuation coverage.

(iv)Equity Awards. Any equity awards subject to time-based vesting (including, without limitation, any awards of stock options, restricted stock, and/or restricted stock units) outstanding as of the date of such termination will vest in full as to 100% of the unvested portion of the award, and, in the case of equity awards subject to performance-based vesting, all performance goals and other vesting criteria will be treated as provided in the equity award agreement governing the award.

(v)Outplacement. The Company will provide reasonable and customary outplacement assistance to Key Associate at the Company's cost for twenty-four (24) months following Key Associate's termination of employment.

(b)Termination without Cause or Resignation for Good Reason outside of the Change of Control Period. If the Company terminates Key Associate's employment with the Company without Cause or if Key Associate resigns from such employment for Good Reason, and such termination occurs outside of the Change of Control Period, and Key Associate signs and does not revoke the Release and provided that the Release becomes effective no later than the Release Deadline, then subject to this Section 4, Key Associate will receive the following:





(i)Accrued Compensation. The Company will pay Key Associate all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to Key Associate under any Company-provided plans, policies, and arrangements.

(ii)Severance Payment. Key Associate will receive (A) continuing payments of severance pay at a rate equal to Key Associate's then-current base salary for twenty-four (24) months from the date of Key Associate's termination of employment, which will be paid in accordance with the Company's normal payroll practices and be subject to the usual, required withholding, and (B) a lump sum cash payment equal to 200% of Key Associate's target bonus for the fiscal year in which the termination of employment occurs or, if Key Associate's target incentive bonus has not yet been established for the fiscal year, the prior fiscal year's target incentive bonus (in each case, less applicable withholding taxes) {the "Bonus Payment"). For the avoidance of doubt, the Bonus Payment will be in lieu of, not in addition to, any annual bonus to which Key Associate would otherwise become entitled for performance during the year in which the termination of employment occurs.

(iii)COBRA. Key Associate will receive a lump sum cash payment in an amount equal to the monthly COBRA premium that Key Associate would be required to pay to continue his group health coverage as in effect on the date of his termination for himself and his eligible dependents, multiplied by eighteen (18), which payment will be made less applicable withholdings and regardless of whether Key Associate elects COBRA continuation coverage.

(iv)Outplacement. The Company will provide reasonable and customary outplacement assistance to Key Associate at the Company's cost for eighteen (18) months following Key Associate's termination of employment.

(c)Timing of Payments. If the Release does not become effective by the Release Deadline, Key Associate will forfeit any rights to severance or benefits under this Agreement. In no event will severance payments or benefits be paid or provided until the Release actually becomes effective. Provided that the Release becomes effective and irrevocable by the Release Deadline, any severance payments or benefits under this Agreement will be paid on, or, in the case of installments, will not commence until, the sixtieth (60th) day following Key Associate's separation from service, or, if later, such time as required by Section 4(g)(ii). Except as required by Section 4(g)(ii), any installment payments that would have been made to Key Associate during the sixty (60) day period immediately following Key Associate's separation from service but for the preceding sentence will be paid to Key Associate on the sixtieth (60th) day following Key Associate's separation from service and the remaining payments will be made as provided in this Agreement. In no event will Key Associate have discretion to determine the taxable year of payment for any Deferred Compensation Separation Benefits.

(d)Voluntary Resignation: Termination for Cause. If Key Associate's employment with the Company terminates (i) voluntarily by Key Associate (other than for Good Reason) or (ii) for Cause by the Company, then Key Associate will not be entitled to receive severance or other benefits except for those (if any) as may then be established under the Company's then existing severance and benefits plans and practices or pursuant to other written agreements with the Company.

(e)Disability· Death. If the Company terminates Key Associate's employment as a result of Key Associate's Disability, or Key Associate's employment terminates due to his death, then Key Associate will not be entitled to receive any other severance or other benefits except for those (if any) as may then be established under the Company's then existing written severance and benefits plans and practices or pursuant to other written agreements with the Company.

(f)Exclusive Remedy. In the event of a Change of Control, or a termination of Key Associate's employment as set forth in Section 4(a) or Section 4(b) of this Agreement, the provisions of Section 3 and Section 4 are intended to be and are exclusive and in lieu of any other rights or remedies to which Key Associate or the Company may otherwise be entitled, whether at law, tort or contract, in equity, or under this Agreement (other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses). Key Associate will be entitled to no benefits, compensation or other payments or rights upon a Change of Control, a termination of employment following a Change of Control or



a termination of employment other than those benefits expressly set forth in Section 3 or Section 4 of this Agreement.



(g)Section 409A.

(i)Notwithstanding anything to the contrary in this Agreement, no severance pay or benefits payable or provided to Key Associate, if any, pursuant to this Agreement, when considered together with any other severance payments or separation benefits that are considered deferred compensation under Section 409A of the Internal Revenue Code of 1986, as amended (the "Code") and the final regulations and any guidance promulgated thereunder ("Section 409A") (together, the "Deferred Compensation Separation Benefits") will be payable until Key Associate has a "separation from service" within the meaning of Section409A. Similarly, no severance payable to Key Associate, if any, pursuant to this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9) will be payable until Key Associate has a "separation from service" within the meaning of Section 409A.

(ii)Notwithstanding anything to the contrary in this Agreement, if Key Associate is a "specified employee" within the meaning of Section 409A at the time of Key Associate's termination (other than due to death), then the Deferred Compensation Separation Benefits that are payable within the first six (6) months following Key Associate's separation from service, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Key Associate's separation from service. All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Key Associate dies following Key Associate's separation from service but prior to the six (6) month anniversary of the separation, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Key Associate's death and all other Deferred Compensation Separation Benefits will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Agreement is intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.

(iii)Any amount paid under this Agreement that satisfies the requirements of the "short-term deferral" rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute Deferred Compensation Separation Benefits for purposes of clause (i) above.

(iv)Any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that do not exceed the Section 409A Limit (as defined below) will not constitute Deferred Compensation Separation Benefits for purposes of clause (i) above.

(v)The foregoing provisions are intended to comply with or be exempt from the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply or be exempt. The Company and Key Associate agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Key Associate under Section 409A. In no event will the Company reimburse Key Associate for any taxes that may be imposed on Key Associate as a result of Section 409A.

(h) Other Requirements. Key Associate's receipt of any payments or benefits under this Section 4 will be subject to Key Associate continuing to comply in all material respects with the terms of any confidential information agreement executed by Key Associate in favor of the Company and the provisions of this Agreement.

(i) Termination of Employment. In the event Key Associate's employment with the Company terminates for any reason, Key Associate will be entitled to any (a) unpaid base pay accrued up to the effective date of termination; (b) pay for accrued but unused vacation; (c) benefits or compensation as




provided under the terms of any employee benefit and compensation agreements or plans applicable to Key Associate, and (d) unreimbursed business expenses required to be reimbursed to Key Associate.

5.Limitation on Payments. In the event that the severance and other benefits provided for in this Agreement or otherwise payable to Key Associate (i) constitute "parachute payments" within the meaning of Section 280G of the Code, and (ii) but for this Section 5, would be subject to the excise tax imposed by Section 4999 of the Code, then Key Associate's benefits under Section 3 and Section 4 respectively will be either:

(a)delivered in full, or

(a)delivered as to such lesser extent which would result in no portion of such benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Key Associate on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code. If a reduction in severance and other benefits constituting "parachute payments" is necessary so that benefits are delivered to a lesser extent, reduction will occur in the following order: (i) reduction of cash payments in reverse chronological order (that is, the cash payment owed on the latest date following the occurrence of the event triggering the excise tax will be the first cash payment to be reduced); (ii) cancellation of equity awards that were granted "contingent on a change in ownership or control" within the meaning of Code Section 280G (if two or more equity awards are granted on the same date, each award will be reduced on a pro-rata basis); (iii) reduction of the accelerated vesting of equity awards in the reverse order of date of grant of the awards (i.e., the vesting of the most recently granted equity awards will be cancelled first and if more than one equity award was made to Key Associate on the same date of grant, all such awards will have their acceleration of vesting reduced pro rata); and (iv) reduction of employee benefits in reverse chronological order (i.e., the benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first benefit to be reduced). In no event will Key Associate have any discretion with respect to the ordering of payment reductions.

Unless the Company and Key Associate otherwise agree in writing, any determination required under this Section 5 will be made in writing by the Company's independent public accountants immediately prior to a Change of Control or such other person or entity to which the parties mutually agree (the "Accountants"), whose determination will be conclusive and binding upon Key Associate and the Company for all purposes. For purposes of making the calculations required by this Section 5, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Key Associate will furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section. The Company will bear all costs the Accountants may incur in connection with any calculations contemplated by this Section 5.


6.Definition of Terms. The following terms referred to in this Agreement will have the following meanings:

(a)Cause. "Cause" will mean Key Associate's termination only upon:

(i)Key Associate's willful failure, after receipt of at least one written warning,
(A) to comply in all material respects with the Company's policies and practices applicable to the Company's employees in similar job positions or to the Company's employees generally or (8) to follow the reasonable instructions of the Board;

(ii)Key Associate's engaging in willful misconduct which is demonstrably and materially injurious to the Company;

(iii)Key Associate's committing a felony, an act of fraud against, or the misappropriation of property belonging to the Company; or




(iv)Key Associate's breaching in any material respect the terms of this Agreement or the Employee, Confidential Information, and Invention Assignment Agreement between Key Associate and the Company.

Except with respect to Section 6(a)(iii), Key Associate shall have fifteen (15) days from the delivery of written notice by the Company of the act or omission that constitutes Cause within which to cure (to the extent curable) any such act or omission to the reasonable satisfaction of the Board. For purposes of the definition of "Cause," no act or failure to act, on the part of Key Associate, shall be considered "willful" unless it is done, or omitted to be done, by Key Associate in bad faith or without reasonable belief that Key Associate's action or omission was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the instructions of the Board or based upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by Key Associate in good faith and in the best interests of the Company.

(b) Change of Control. "Change of Control" will mean the occurrence of any of the following events:

(i)Change in Ownership of the Company. A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group ("Person"), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than 50% of the total voting power of the stock of the Company, except that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Board will not be considered a Change of Control; or

(ii)Change in Effective Control of the Company. A change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this clause (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change of Control; or

(iii)Change in Ownership of a Substantial Portion of the Company's Assets. A change in the ownership of a substantial portion of the Company's assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions. For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.

For these purposes, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.

Notwithstanding the foregoing provisions of this definition, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within the meaning of Section 409A.

(c)Change of Control Period. "Change of Control Period" will mean the twenty-four (24) month period on or following the first Change of Control to occur following the Effective Date.

(d)Disability. "Disability" will mean that Key Associate is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months. Termination resulting from Disability may only be effected after at least thirty (30) days' written notice by the Company of its intention to terminate Key Associate's employment. In the event that Key Associate resumes the performance of substantially all of his duties hereunder before the termination of his employment becomes effective, the notice of intent to terminate will automatically be deemed to have been revoked.




(e)Good Reason. "Good Reason" will mean Key Associate's termination of employment within ninety (90) days following the expiration of any cure period (discussed below) following the occurrence of one or more of the following, without Key Associate's consent:

(i)A material reduction in Key Associate's base compensation as in effect immediately prior to such reduction not including a substantially similar reduction that applies to similarly situated executives;

(ii)The assignment to Key Associate of any duties, or the reduction of Key Associate's duties, either of which results in a material diminution of Key Associate's authority, duties, or responsibilities with the Company in effect immediately prior to such assignment or reduction, or the removal of Key Associate from such position and responsibilities, provided that such removal results in a material diminution of Key Associate's authority, duties, or responsibilities with the Company;

(iii)A material change in the geographic location at which Key Associate must perform services (in other words, the relocation of Key Associate to a facility that is more than fifty (50) miles from Key Associate's current location);

(iv)The Company gives notice to Key Associate that the term of this Agreement shall not be extended and shall terminate on the next Renewal Date; or

(v)the failure of the Company to obtain the assumption of the Agreement by a successor and/or acquirer.

Key Associate will not resign for Good Reason without first providing the Company with written notice within ninety (90} days of the event that Key Associate believes constitutes "Good Reason" specifically identifying the acts or omissions constituting the grounds for Good Reason and a reasonable cure period of not less than thirty (30} days following the date of such notice.

(f)Section 409A Limit. "Section 409A Limit" will mean two (2) times the lesser of: (i} Key Associate's annualized compensation based upon the annual rate of pay paid to Key Associate during Key Associate's taxable year preceding Key Associate's taxable year of Key Associate's termination of employment as determined under, and with such adjustments as are set forth in, Treasury Regulation 1.409A- 1(b}(9}(iii}(A}(1) and any Internal Revenue Service guidance issued with respect thereto; or (ii} the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a}(17} of the Code for the year in which Key Associate's employment is terminated.

7.Successors.

(a)The Company's Successors. Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise} to all or substantially all of the Company's business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term "Company" will include any successor to the Company's business and/or assets which executes and delivers the assumption agreement described in this Section 7(a} or which becomes bound by the terms of this Agreement by operation of law.

(b)Key Associate's Successors. The terms of this Agreement and all rights of Key Associate hereunder will inure to the benefit of, and be enforceable by, Key Associate's personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

8.Arbitration.
(a)The Company and Key Associate each agree that any and all disputes arising out of the terms of this Agreement, Key Associate's employment by the Company, Key Associate's service as an




officer or director of the Company, or Key Associate's compensation and benefits, their interpretation and any of the matters herein released, will be subject to binding arbitration under the arbitration rules set forth in California Code of Civil Procedure Sections 1280 through 1294.2, including Section 1281.8 (the "Act"), and pursuant to California law. Disputes that the Company and Key Associate agree to arbitrate, and thereby agree to waive any right to a trial by jury, include any statutory claims under local, state, or federal law, including, but not limited to, claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the Sarbanes-Oxley Act, the Worker Adjustment and Retraining Notification Act, the California Fair Employment and Housing Act, the Family and Medical Leave Act, the California Family Rights Act, the California Labor Code, claims of harassment, discrimination, and wrongful termination, and any statutory or common law claims. The Company and Key Associate further understand that this agreement to arbitrate also applies to any disputes that the Company may have with Key Associate.

(a)Procedure. The Company and Key Associate agree that any arbitration will be administered by Judicial Arbitration & Mediation Services, Inc. ("JAMS"), pursuant to its Employment Arbitration Rules & Procedures (the "JAMS Rules"). The Arbitrator will have the power to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication, motions to dismiss and demurrers, and motions for class certification, prior to any arbitration hearing. The Arbitrator will have the power to award any remedies available under applicable law, and the Arbitrator will award attorneys' fees and costs to the prevailing party, except as prohibited by law. The Company will pay for any administrative or hearing fees charged by the Arbitrator or JAMS except that Key Associate will pay any filing fees associated with any arbitration that Key Associate initiates, but only so much of the filing fees as Key Associate would have instead paid had he filed a complaint in a court of law. The Arbitrator will administer and conduct any arbitration in accordance with California law, including the California Code of Civil Procedure, and the Arbitrator will apply substantive and procedural California law to any dispute or claim, without reference to rules of conflict of law. To the extent that the JAMS Rules conflict with California law, California law will take precedence. The decision of the Arbitrator will be in writing. Any arbitration under this Agreement will be conducted in Santa Cruz County, California.

(b)Remedy. Except as provided by the Act and this Agreement, arbitration will be the sole, exclusive, and final remedy for any dispute between. Key Associate and the Company. Accordingly, except as provided for by the Act and this Agreement, neither Key Associate nor the Company will be permitted to pursue court action regarding claims that are subject to arbitration.

(c)Administrative Relief. Key Associate understands that this Agreement does not prohibit him from pursuing any administrative claim with a local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, including, but not limited to, the Department of Fair Employment and Housing, the Equal Employment Opportunity Commission, the National Labor Relations Board, or the Workers' Compensation Board. This Agreement does, however, preclude Key Associate from pursuing court action regarding any such claim, except as permitted by law.

(d)Voluntary Nature of Agreement. Each of the Company and Key Associate acknowledges and agrees that such party is executing this Agreement voluntarily and without any duress or undue influence by anyone. Key Associate further acknowledges and agrees that he has carefully read this Agreement and has asked any questions needed for him to understand the terms, consequences, and binding effect of this Agreement and fully understand it, including that Key Associate is waiving his right to a jury trial. Finally, Key Associate agrees that he has been provided an opportunity to seek the advice of an attorney of his choice before signing this Agreement.

9.Notice.

(a)General. Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have been duly given when personally delivered when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid or when delivered by a private courier service such as UPS, OHL or Federal Express that has tracking capability. In the case of Key Associate, mailed notices will be addressed to him at the home address which he most recently communicated to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all notices will be directed to the attention of its President.




(b)Notice of Termination. Any termination by the Company for Cause or by Key Associate for Good Reason will be communicated by a notice of termination to the other party hereto given in accordance with Section 9(a) of this Agreement. Such notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and will specify the termination date {which will be not more than ninety (90) days after the giving of such notice). The failure by Key Associate to include in the notice any fact or circumstance which contributes to a showing of Good Reason will not waive any right of Key Associate hereunder or preclude Key Associate from asserting such fact or circumstance in enforcing his rights hereunder.

10.Miscellaneous Provisions.

(a)No Duty to Mitigate. Key Associate will not be required to mitigate the amount of any payment contemplated by this Agreement, nor will any such payment be reduced by any earnings that Key Associate may receive from any other source.

(b)Waiver. No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Key Associate and by an authorized officer of the Company (other than Key Associate). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time.

(c)Headings. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.

(d)Entire Agreement. This Agreement constitutes the entire agreement of the parties hereto and supersedes in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied} of the parties with respect to the subject matter hereof. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto and which specifically mention this Agreement.

(e)Choice of Law. The validity, interpretation, construction and performance of this Agreement will be governed by the laws of the State of California (with the exception of its conflict of laws provisions). Any claims or legal actions by one party against the other arising out of the relationship between the parties contemplated herein (whether or not arising under this Agreement) will be commenced or maintained in any state or federal court located in the jurisdiction where Key Associate resides, and Key Associate and the Company hereby submit to the jurisdiction and venue of any such court.

(f)Severability. The invalidity or unenforceability of any provision or provisions of this Agreement will not affect the validity or enforceability of any other provision hereof, which will remain in full force and effect.

(g)Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable income, employment and other taxes.

(h)Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.

[Signature Page to Follow]









IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year set forth below.

COMPANY                PLANTRONICS, INC.


By: /s/ Gregg Hammann

Printed Name: Gregg Hammann

Title: Chairman of the Leadership Development and Compensation Committee of the Board of Directors

Date:

KEY ASSOCIATE By: /s/ David Shull

Name: David Shull

Title: Chief Executive Officer

Date: August 16, 2020

































EXHIBIT A
RELEASE OF CLAIMS




Exhibit 31.1
Certification of the President and CEO
I, David M. Shull, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Plantronics, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
October 29, 2020
/s/ David M. Shull
David M. Shull
President, Chief Executive Officer and Director




Exhibit 31.2
Certification of the Executive Vice President and CFO
I, Charles D. Boynton, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Plantronics, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
October 29, 2020
/s/ Charles D. Boynton
Charles D. Boynton
Executive Vice President and Chief Financial Officer



Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, David M. Shull, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Plantronics, Inc. on Form 10-Q for the period ended September 26, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Plantronics, Inc.
By: /s/ David M. Shull
Name: David M. Shull
Title: President, Chief Executive Officer and Director
Date: October 29, 2020

I, Charles D. Boynton, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Plantronics, Inc. on Form 10-Q for the period ended September 26, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Plantronics, Inc.
By: /s/ Charles D. Boynton
Name: Charles D. Boynton
Title: Executive Vice President and Chief Financial Officer
Date: October 29, 2020

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.